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In the United States, Colorectal Cancer (CRC) is the third leading cause of cancer-related 
deaths in both males and females. In 2017, it was estimated that 50,260 people would die 
from colon cancer alone (American Cancer Society, 2017). There are several behavioral 
factors that are known to reduce the risk of CRC. Studies have shown that less smoking, 
reduced heavy alcohol use, engaging in regular physical activity and healthy eating habits 
are associated with a lower risk of developing colorectal cancer (Lynes et al, 2016). In 
recent studies, researchers found an inverse relationship between Calcium and Vitamin D 
use and colorectal cancer through various mechanisms (Chan & Giovannucci, 2010). 
However, the role of other supplements, including multi-vitamins, vitamin C, and vitamin 
B6, remains uncertain; there have only been a few studies conducted with these other 
supplements and their role in colon cancer risk reduction. According to Consumer Survey 
on Dietary Supplements, 68% of U.S. adults report that they use a dietary supplement and 
  
over 50% are regular users. NHANES survey shows that women, older adults and whites 
use supplements more than their counterparts (Picciano, 2005).  
A survey was administered to patients prior to their colonoscopy appointment to 
investigate perceived and actual understanding of the procedure, health literacy, and 
general health. Participants were selected from eligible patients (18 years or older; could 
read/write English; cognitively able to fill out survey) scheduled for a colonoscopy at 
either a university hospital-based center or a university-affiliated outpatient endoscopy 
center situated in Alachua County, Florida from September 2011 through October 2013 
(Curbow et al, 2015). The goal of this proposed Master’s thesis capstone is to conduct a 
secondary analysis of data collected from patients in this study to determine associations 
regarding supplement use with various variables such as demographic factors, perceived 
health literacy, informed about CRC, concern about CRC, reason for colonoscopy and 
general health. These associations will help us to better understand how these variables 
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Chapter 1: Introduction 
Statement of Research Problem 
While most professional nutrition organizations, including the Academy of 
Nutrition and Dietetics, do not advocate that healthy adults use vitamin and mineral 
supplements, these organizations do recognize that there are population subgroups for 
which a supplement may be warranted to ensure that nutrient needs are fully met 
(Rodriquez & DiMarco, 2009). A supplement is a substance that is ingested and contains 
a dietary ingredient that provides additional nutritional value to one’s diet (ODS, 2011). 
Scientists have not reached a uniform consensus on whether the use of supplements on a 
routine basis is beneficial, yet a large portion of the U.S. population (about 2/3rds) have 
used multivitamins and other dietary supplements (Bailey et al, 2011; Radimer et al, 
2004; Foote et al, 2003; Dickenson et al, 2014). Renowned scientists have suggested the 
regular use of multivitamins for adults as a way to obtain nutrients they do not receive 
from their diet, to guarantee that the body functions properly and to support health in 
general (FDA, 2017). A new explanation behind the suggestion of supplement use is that 
they have the potential to protect against chronic disease (Frei et al, 2014; Ames et al, 
2007; Willett and Stampfer, 2001). On the other hand, some scientists oppose the regular 
use of supplements; mainly because supplements have not been proven to produce 
considerable protection against chronic diseases particularly heart disease and cancer 
(Guallar et al, 2013). However, other scientists believe that the regular use of 







elderly) to safeguard the appropriate dietary intake of essential vitamins and minerals 
(FDA, 2017). 
 
Guidelines for Supplement Use 
 There are several suggested guidelines for supplement use. First, it is important to 
know the composition of the supplement that is used and how it will react with the body. 
Although supplements have provided positive health effects, some have produced 
negative side effects. Second, it is also important to check the Percent Daily Value to 
ensure that the amount taken is correct and is not more than the recommended amount 
(FDA, 2017). Lastly, it is advised that individual check to see what research has been 
done on the supplements they use. R esearchers have demonstrated that several 
supplements have certain benefits and are linked with positive health outcomes (Albert et 
al, 2008; Ruxton, 2004; Prentice et al, 2013). Nevertheless, researchers need to conduct 
clinical trials on supplements that we have no information about so we can understand 
their effects (both positive and negative). 
Current Supplement Recommendations 
There are several supplements that have been recommended for use by certain 
populations. Folic acid supplementation has been shown to prevent neural tube defects 
and other folic acid–sensitive congenital malformations. Therefore, it is recommended 
that pregnant women and women of childbearing age consume 0.4-1.0 mg of folic acid 
daily as part of their diet (Chitayat et al, 2016).  Along with folic acid, iron supplements 
are also recommended for pregnant women (Rioux and LeBlanc, 2007). Breastfed infants 







benefit of their child (CDC, 2015). Moreover, Vitamin D deficiency is epidemiologically 
linked to prostate and colon cancer, especially among Black men. Thus, vitamin D use is 
suggested for Black men due to the high prevalence of vitamin D deficiency among this 
population; vitamin D is essential for bone formation, resorption, and mineralization 
(Murphy et al, 2012).  
Calcium not only helps to manage osteoporosis, but a diet high in calcium can 
prevent the development of osteoporosis. The use of calcium is advised by practitioners 
to those who have osteoporosis because calcium plays a vital role in preventing fractures 
and the loss of bone mass (Sunyecz, 2008). Along with vitamin D and calcium, the 
National Institute on Aging (NIA) Vitamin and Mineral Intake Guidelines for seniors 
recommends that the elderly include Vitamin B12, and iron supplements as part of their 
diet. Vitamin B12 supplements are suggested for the elderly because they have problems 
absorbing vitamin B12 that is found in foods naturally; this vitamin is needed keep the 
body’s nerve and blood cells healthy and to prevent weakness/tiredness among this 
population (ODS, 2011). Anemia is common in the elderly and its prevalence increases 
with age; the most common causes are chronic disease and iron deficiency (Smith, 2000). 
Iron supplements are especially needed among this group to decrease likelihood of 
anemia and iron is needed to generate red blood cells which deliver oxygen to tissues 
throughout the body (NIA, 2013). Lastly, it is advised that vegans also consider taking 
Vitamin B12 supplements which comes mostly from meat, fish and dairy products, foods 
that are not allowed in their diet. Individuals with any heart condition have been guided 
to take fish oil (omega-3 fatty acids) because research has suggested that it promotes 







highlight the importance of using these supplements and the health benefits that 
accompany it. 
Current Supplement Trends 
Dietary supplement usage is common among Americans. According to 2011-2014 
National Health and Nutrition Examination Surveys (NHANES) data, approximately half 
of Americans use dietary supplements, with multivitamin/mineral supplements (MVS) 
consumed most frequently (Gahche et al, 2017). Supplements are used mostly among 
White women, but other populations (men, racial minorities, low income and low 
education individuals) are thought to be missing out on the benefits of supplement use 
(Blumberg et al, 2016). Trends in dietary supplements were assessed among individuals 
living in the US every 2 years from 1999 to 2012; supplement use was found to be 
associated with several sociodemographic variables. Supplement use was highest among 
Non-Hispanic Whites (58%) and lowest among Mexican Americans (29%) (Kantor et al, 
2016). Women were also more likely to use supplements than men, 58% and 45% 
respectively (Kantor et al, 2016). Supplement use increased with age, with 72% of adults 
65 years or older reporting use compared with 40% of adults aged 20-39 years (Kantor et 
al, 2016). As people get older they may not obtain these nutrients from their diet so they 
rely on supplements as the source of these essential nutrients. There is a correlation 
between education and the use of supplements, with those having higher education using 
more supplements compared to those with lower education. Supplement use among 
individuals with 4 or more years of secondary education (65%) was greater compared to 
those with less than a high school diploma (37%) (Kantor et al, 2016). Supplements have 







health (Kantor et al, 2016). Along with supplements, there are different approaches that 
are recommended for individuals to implement in their lives in order to keep and 
maintain their health (Young, 2014). This is particularly true for preserving and 
maintaining colon health (Chan and Giovannucci, 2010). 
Colon Health Recommendations 
There are several strategies individuals can adapt to their lifestyle to improve the 
health of their colon and lower their risk of developing colorectal cancer. First, it is 
essential to maintain a healthy diet; consuming more fruits, vegetables, grains and nuts 
which aid in the normal function of the bowel. However, it is best to avoid red meat, 
processed food and foods high in fat (Nomura et al, 2016). Second, those who are obese 
or overweight have an increased risk of developing colorectal cancer. Therefore, regular 
engagement in physical activity each week (150 minutes of moderate-intensity) is 
advised in order to maintain a healthy weight and decrease the risk of obesity (Howard et 
al, 2008; American Cancer Society, 2017). Third, alcohol and tobacco usage should be 
decreased in order to improve the health of the colon. The use of alcohol should be 
limited (<12.5 grams per day, about one drink) in order to maintain a colon that is healthy 
and functional (American Cancer Society, 2017). In regards to tobacco use, smoking can 
lead to carcinogens entering the colorectal mucosa either through ingestion or the 
circulatory system. These carcinogens then result in the formation of adenomas, which 
are precursor lesions that disrupt the normal function of the colon and increase the risk of 
colorectal cancer (Paskett et al, 2007). Finally, once individuals (both men and women) 







Screening is needed so that polyps and cancer can be detected early and the correct 
treatment administered to the individual (American Cancer Society, 2017). 
Research Questions 
1. Among a group of pre-colonoscopy individuals, how do rates of supplement use 
differ by various demographic and conceptual characteristics? 
1.1. What is the rate of supplement use (type of supplement use, any 
supplement use and protective supplement use)? 
1.2. How is this rate associated with age, gender, race, income, and education? 
1.3. How is this rate associated with perceived health literacy and informed 
about CRC? 
1.4. How is this rate associated with concern about CRC and reason for 
colonoscopy? 
2. Among a group of pre-colonoscopy individuals, is general health associated with 
supplement use (type of supplement use and any supplement use)? 
2.1 How is health status associated with supplement use? 
2.2. How is physical health associated with supplement use? 
2.3. How is mental health associated with supplement use? 
Definition of Terms 









1. Adenomas The most common precancerous colon polyp, which is believed to be 
the precursor for about 80% of CRC (Cleveland Clinic, 2017). 
2. Carcinogens Substances that are known to cause cancer (American Cancer Society, 
2017). 
3. Carcinoma Cancer that begins in the skin or in tissues that line or cover internal 
organs (National Cancer Institute, 2017). 
4. Colonoscopy A screening or diagnostic exam for colorectal cancer in which a 
lighted tube with a small camera on the end is used to examine the 
entire length of the colon and rectum. If polyps are found, they may be 
removed during the test (American Cancer Society, 2016). 
5. Colorectal Cancer Cancer that occurs in the colon or rectum; the colon is part of the large 
intestine or large bowel and the rectum is the channel that connects the 
colon to the anus (Colon Cancer Alliance, 2017). 
6. Health Disparity “A particular type of health difference that is closely linked with 
social, economic, and/or environmental disadvantage. Health 
disparities adversely affect groups of people who have systematically 
experienced greater obstacles to health based on their racial or ethnic 
group; religion; socioeconomic status; gender; age; mental health; 
cognitive, sensory, or physical disability; sexual orientation or gender 
identity; geographic location; or other characteristics historically 
linked to discrimination or exclusion” (Healthy People 2020, 2017). 
7. Polyps Abnormal growths inside the colon or rectum that may later become 
cancerous if not removed (Colon Cancer Alliance, 2017). 
8.Supplements A nutrient that may be added to the diet to increase the intake of that 
nutrient (Office of Dietary Supplement [ODS], 2017). 
Included in analysis: 
9. Concern about 
Colorectal Cancer 
How susceptible people think they are of developing colorectal cancer 
(Orji et al, 2012). 
10. Informed about 
Colorectal Cancer 
What people think they know about colorectal cancer (Greiner et al, 
2005). 
11. Reason for 
Colonoscopy 
A trigger that elicits a response for people to engage in a health 
behavior, in this case it is why the colonoscopy was ordered and its 







12. Multivitamins It is associated with better performance or energy, weight control, or 
improved immunity, typical dosage is one pill daily (ODS, 2106).. 
13. Aspirin It limits the clumping of platelets, which can prevent a heart attack or 
stroke form occurring, typical dosage (75-325mg) is based on doctor’s 
recommendation (Mayo Clinic, 2017). 
14. Calcium It is associated with maintaining and supporting the structure of bones 
and teeth and helping in the process to release hormones and enzymes, 
typical dosage is 1000 and 1200mg daily for adult men and women 
respectively (ODS, 2016). 
15. Vitamin C It is associated with protecting cells from the harm caused by free 
radicals and making collagen, a protein that aids in the wound healing 
process, typical dosage is 90 and 75mg daily for adult men and women 
respectively (ODS, 2016). 
16. Vitamin D It is associated with aiding cells to uptake calcium, muscle movement, 
carrying messages through the nerve form the brain to different parts 
of the body and the immune system’s role in fighting invaders such as 
bacteria/viruses, typical dosage is 600 IU(402 mg) daily for adult men 
and women (ODS, 2016). 
17. Fish Oil It is a source of omega-3, which is needed to improve the structure of 
the cell membrane and production of signaling molecules, typical 
dosage is 1.6g and 1.1g daily for adult men and women respectively. 
(ODS, 2016). 
Table 1: Definition of terms that the audience may not know but need to understand in order to 
comprehend the concepts in this paper. 
 
Significance of the Project 
The significance of this proposal will be for this population of pre-colonoscopy 
individuals to understand what supplements are and to communicate with their doctor to 
determine if they are a good candidate for using supplements. It is crucial to identify (1) 
groups using and not using supplements, (2) the facilitators and barriers to supplement 
use and (3) interventions to reduce disparities in supplement use. It is very important that 







their health care provider. This provides them with a good understanding of what they are 
actively doing to manage their health and help them to provide coordinated and safe care 
(ODS, 2017). 
 First, it is important that people understand the purpose of supplements and how 
they should be used. It is believed that supplements, such as vitamins, minerals and 
herbal products have the essential nutrients required to maintain or improve health (ODS, 
2016).  Supplements users should know that supplements are not a substitute for a 
healthy, nutritious and varied diet (Dickinson et al, 2015). People need to understand that 
supplements should be taken only if a medical care provider determines they are not able 
to acquire the essential nutrients from their normal diet. This can happen as a result of not 
consuming a variety of foods or the body lacking the ability to absorb these nutrients 
directly from the environment or from food. Dietary supplements can consist of several 
ingredients, such as vitamins, minerals, amino acids, and herbs or other botanicals, which 
the body requires to function. It is also necessary to educate individuals as to the impacts 
(positive and negative) that supplements can have on their health. Researchers have 
proven that some supplements can provide health benefits, but have not confirmed the 
effects of other supplements (ODS, 2017). 
Second, it is essential that individuals talk with their health care providers before 
they decide to use supplements. Doctors should explain if and how supplement(s) will 
affect their patients. Some dietary supplements may interact with medications that a 
person is taking or they may be considered hazardous if you have a medical problem 
(ODS, 2017). Some dietary supplements have yet to be assessed in certain populations, 







need to be very careful of what they are introducing into their body; supplements can 
potentially lead to negative side effects. The U.S. Food and Drug Administration (FDA) 
is responsible for regulating dietary supplements, but the regulations are different from 
and less stringent than regulations for prescriptions and over-the-counter drugs (ODS, 
2017). Prescriptions are tightly regulated and require a doctor’s approval because they 
have the potential to lead to adverse health outcomes. Similarly, supplements should be 
taken seriously, not taken haphazardly, but taken with recommendation from a doctor. 
Supplements have been shown to have some positive effects on health. However, 
certain groups that can benefit from using supplements are not typical users. Non-
Hispanic White women are more likely to use supplements; especially those of among 
the middle and older age groups, with high education and high income (Jasti et al, 2003). 
Black, Hispanic, Asian, Pacific Islander and Native American women disproportionately 
use supplements less than White women (Jasti et al, 2003). There might be barriers and 
cultural beliefs that prevent minority women form using supplements. Moreover, the 
number of men who take supplements is less than the number of women who use 
supplements (Hensley, 2011). There are several factors that influence supplement use; 
these include age, race, gender and culture. Disparities in supplement use needs to be 







Chapter 2: Background 
Conceptual Framework 
A theory or conceptual framework presents a logical and organized way of 
comprehending events or situations that happen. It usually contains a set of concepts, 
definitions, and propositions that try to explain or predict events or outcomes that occur 
by expounding upon the relationships that exist between variables (Glanz et al, 1997). As 
illustrated in Figure 1, a conceptual framework consisting of several constructs would be 
used to explain supplement use among a population of people who are scheduled to have 
colonoscopy. The first construct is demographic factors (age, gender, race, income, and 
education). Demographic factors are characteristics that define a person and these factors 
significantly influence health behaviors that individuals choose to engage in (Foote et al, 
2003).  
The second construct is perceived health literacy; "the degree to which individuals 
have the capacity to obtain, process, and understand basic health information and services 
needed to make appropriate health decisions” (Institute of Medicine, 2004, pg 31; 
National Network of Libraries of Medicine, 2017).  The understanding of information 
pertaining to CRC influences supplement use. Another construct that is tied with 
perceived health literacy is informed about CRC. The third construct, informed about 
CRC is defined as what people think they know regarding a certain subject or topic 
(Greiner et al, 2005). In this case, it is how informed people are about colon and rectal 
cancer. The fourth construct, concern about CRC refers to the probability that individuals 







is measured by how concerned people are about having colon or rectal cancer. It can be 
hypothesized that those with a high perceived susceptibility would have taken measures, 
such as using supplements, to reduce their risk of developing CRC. The fifth construct is 
reason for colonoscopy; it is a trigger to engage in a health behavior. The trigger can be 
events, people, or things that prompt people to change their behavior. The trigger can 
include internal cues such as a harmful change in the body or discernment of signs and 
indicators of impairment (Orji et al, 2012).  Individuals may choose to have a 
colonoscopy because they are experiencing symptoms of CRC or a follow-up to an 
abnormal test or previous colonoscopy. The last construct is general health, with health 
status, physical and mental health as underlying variables. People who are actively trying 
to maintain or improve their health overall would be more likely to consider using 
supplements (NCCIH, 2014). These constructs, individually and collectively, play an 
essential role in supplement use among this population. 








Figure 1: In regards to supplement use, there are several variables of interest that were analyzed to see if 
an association existed. 
 
Cancer 
Outranked by heart disease, cancer is the second leading cause of death in the 
United States, about half a million people die from cancer each year in the U.S (Center 
for Disease Control, 2017). Cancer involves the growth of abnormal cells that specifically 
affect a certain part of the body. However, these abnormal cells can metastasize to other 
parts of the body (American Cancer Society, 2015). If these abnormal cells are malignant, 
in a state of causing harm, then they can interrupt the body’s normal routine in 
maintaining stable working systems, which can lead to a decrease in quality of life 
(American Cancer Society, 2015). The body can no longer perform the necessary 
functions to be operational so patients can no longer engage in the activities they usually 
do. Cancer not only affects the physical state but it also affects the emotional, mental, 
social, and behavioral states (Heydarnejad et al 2011). Consequently, cancer can affect all 
aspects of one’s life and can completely change a patient’s lifestyle. Although there are 
methods to treat cancer, chemotherapy and radiation being two of the most common, 
some methods have many negative side effects, such as hair loss and killing of healthy 
cells (American Cancer Society, 2015).  Also, the cost of diagnosing and treating cancer 
is very high; surgical complications, hospital lengths of stay, and hospital readmissions, 
can increase overall health care costs (Silver, 2015). It might strain patient’s financial 







Currently, there are about seventeen major types of cancer; this proposal will focus on 
one specific cancer. 
Colorectal Cancer 
Colorectal Cancer (CRC) is cancer of the colon or rectum, located at the digestive 
tract's lower end (CDC, 2017). CRC is the third most common cause of death by cancer 
in both men and women in the U.S. (Parikh et al, 2014). In 2017, the American Cancer 
Society estimated that 135,430 people in the United States would be diagnosed with 
colorectal cancer. Along with high morbidity, CRC also has high mortality if diagnosed 
at later stages. In 2017, the American Cancer Society also estimated that 50,260 people in 
the United States would die from colorectal cancer, including 27,150 men and 23,110 
women (American Cancer Society, 2017). 
There are several identifiable trends in CRC with regard to race/ethnicity, gender, 
and age. In relation to race, CRC incidence and death rates are highest in Blacks and 
lowest in Asians/Pacific Islanders. Among males, during 2006 through 2010, the death 
rate in Blacks (29.4 per 100,000 population) was twice as high as the rate in 
Asians/Pacific Islanders (13.1) and higher than the rate of Non-Hispanic Whites (19.2) 
(Siegel et al, 2014). In regard to gender, men are more likely to develop CRC compared 
to women. About 1 or 2 out of every 100 men who are 60 years old today will get 
colorectal cancer by the age of 70 (CDC, 2015). The chance of developing CRC increases 
as age increases, with the majority of CRC cases diagnosed in individuals who are 60 
years or older (Pusatcioglu and Braunschweig, 2011). However, there has been a new 







cancer cases among the younger than 50 adult population in the U.S. While examining 
trends in CRC recent population based study, researchers found an increase in the 
incidence of CRC among young and middle aged adults. The study found an increase in 
CRC incidence from 1% to 2% in adults ages 20-39 and from 0.5% to 1% in adults ages 
40-54 (American Cancer Society, 2017).  
The incidence of CRC is decreasing and patients with CRC are living much 
longer now than before due to advances in screening and treatment methods (Tong et al, 
2014). From 1975 to 2009, there has been a 45% drop in the CRC mortality rate. 
Although screening is leading to improvements, the number of people dying from CRC is 
still high, and health disparities in CRC screening and treatment are major issues that 
need more attention. Fortunately, there are certain actions that individuals can perform to 
prevent the development of CRC. 
Colorectal Cancer Prevention 
There are several behavioral strategies believed to reduce the risk of CRC, such as 
decreased tobacco and alcohol use, increased physical activity, and better eating habits, 
such as increasing fruit and vegetable intake (Chan and Giovannucci, 2010). More 
recently, evidence has suggested that supplement use may reduce risk of CRC 
(Hoffmeister et al, 2011, Wactawski et al, 2006; Pericleous et al, 2013, American Cancer 
Society, 2016). 
Most well-known preventative strategies in decreasing CRC risk involves 
decreasing the use of tobacco and alcohol. Tobacco use has been reported to have a 







precursors to colon cancer. Tobacco usage has been linked to increased risk for colorectal 
adenoma in many epidemiologic studies, in individuals who have been smoking for a 
long period of time (Ji et al, 2006). Carcinogens in cigarette smoke may act to initiate 
tumors in the colon and rectum (Chao et al, 2000). Furthermore, risk is intensified and 
correlated with increasing number of cigarettes usually smoked, duration of cigarette use, 
and pack-years of use (Ji et al, 2006). Thus, a decrease in the use of tobacco would 
decrease the risk of developing these precursors and thus the probability of obtaining 
CRC. 
Another factor in reducing risk of colon cancer is decreased alcohol usage. 
Alcohol consumption is a risk factor for cancers of the mouth, throat, colon, breast, and 
liver (CDC, 2016; Acott, 2008). In particular, moderate to heavy alcohol consumption 
has been shown to be a prominent factor in the early stages of CRC where carcinoma 
development occurs (Wang et al, 2015). This is a precursor lesion that indicates that a 
person is on the path of developing CRC. Therefore, drinking less can decrease the 
likelihood of developing these lesions and reduce the probability of developing CRC. 
Current users of both alcohol and tobacco were associated with a significantly younger 
age of colorectal cancer onset compared with all patients (Acott, 2008; Marley and Nan, 
2014). Reducing tobacco and alcohol use can decrease the probability of developing 
CRC.  
Another way to protect against the risk of acquiring CRC is an increased 
engagement in physical activity. Research has demonstrated that physical activity (PA) is 
correlated to CRC mortality, with about 15% of global CRC deaths being attributed to 







14% of colon cancer can be linked to lack of frequent engagement in vigorous and 
intense physical activity (Slattery, 2004). This is confirmed by a study from the UK in 
which researchers estimated that 12% of colorectal cancers could be prevented by 
individuals increasing the level of physical activity they perform (Anderson et al, 2014). 
Moreover, higher levels of PA in CRC survivors have been associated with a reduced risk 
of the disease recurrence (Sax et al, 2014). Physical activity can increase the life span of 
patients with CRC, allowing them to live longer and have the opportunity to engage in 
activities they wouldn’t have otherwise be able to. Although it is understood that 
increased physical activity is linked with lower colon cancer risk, researchers are not sure 
of the amount, intensity and frequency of PA that is needed for a protective effect 
(Slattery, 2004).  
Along with physical activity, diet has also been shown to reduce CRC risk. 
Researchers have found that eating healthier foods on a regular basis can improve health 
and decrease likelihood of having colon cancer. The consumption of fruits and 
vegetables, particularly dark yellow vegetables and apples, was found to provide a 
significant for a protective effect for CRC (Pusatcioglu & Braunschweig, 2011). Those 
who engage in healthy eating habits have a lower risk of developing CRC compared to 
those who do not. Studies have shown that the presence of colorectal adenomas and 
polyps, which are precursors to colorectal cancer, are associated with unhealthy diet 
patterns (Nomura et al, 2016). An unhealthy diet is high in calories, consumption of red 
meat or processed meat, and foods with a high glycemic index (carbohydrates, snack 
food, fried fast food, sugar-sweetened drinks, and sweets) (Pietrzyk, 2017). Therefore 







reduce the probability of developing colon cancer. Although diet has been proven to 
reduce colorectal cancer risk, less is known about supplement use and its roles in 
decreasing CRC. 
Supplement Use 
People take supplements for various reasons: to acquire essential substances the 
body needs to operate properly to maintain or improve health and to help reduce the risk 
of disease (Food and Drug Administration, 2017). According to the National Health and 
Nutrition Examination Survey (NHANES) survey, among supplement users, 
multivitamins (MVS) were the most commonly used supplement (71%), followed by 
omega-3 or fish oil (33%), calcium (32%), vitamin D (32%), and vitamin C (32%) 
(Dickinson et al, 2014). In the United States the use of supplements is seen more in older 
Non-Hispanic White women, who tend to have higher education and income (Kantor et 
al, 2006). This is not surprising because higher education is correlated with higher 
income and higher income is correlated with better eating habits (Jasai et al, 2003). 
Blacks are inclined to use vitamin D at a rate higher than any other race because they 
tend to be vitamin D deficient (Harris, 2006). In a study among women who have had a 
colonoscopy, these women were more likely to engage in healthy behaviors, such as 
consuming less alcohol, eating more dietary fiber and using supplements, compared to 
women who have not had a colonoscopy (Zhang et al, 2005). The use of supplements was 







Supplement Use and Colorectal Cancer Prevention 
There are several supplements that have been shown to lower a person’s risk of 
obtaining CRC. Higher intake of both vitamin D and calcium separately has been found 
to be associated with lower colorectal cancer risk (Wactawski-Wende et al, 2006 and 
Pericleous et al, 2013). Individuals who were taking multivitamins (MVS) were less 
likely to develop colon cancer than were individuals who did not take multivitamins 
(Zhang et al, 2005). Several studies have shown that, aspirin and statins have protective a 
protective effect against the development of colorectal cancer (Hoffmeister et al, 2007, 
Algra et al, 2012, and Bibbins-Domingo, 2016 and U.S. Preventive Services Task Force, 
2016). Although the mechanism of how supplements interact with the body is unknown, 
researchers have determined that there is an inverse relationship between supplements 
and colorectal cancer (Chan and Giovannucci, 2010, Heine-Broring et al, 2015). While 
we know of the benefits of supplement use and the impact on colorectal health, less is 
known about trends of supplemental use among a pre-colonoscopy population. 
Researchers are unsure of trends in the population in regard to age, gender, race/ethnicity, 
income and education. Identifying and understanding these trends can provide insight 
into developing interventions to increase supplement use among those groups with low 
uptake rates. It is important to determine if there are any health disparities among those 







Chapter 3: Methods 
Overview of Study 
In the proposed work, I conducted secondary data analysis based on collected data 
of over 1800 pre-colonoscopy patients. The data were from a study regarding information 
on the pre-colonoscopy experience of individuals, such as how the colonoscopy came 
about, information seeking, beliefs and expectations, and levels of concern. The principal 
investigator of the research study was Dr. Barbara Curbow. I was not a part of the 
original research team, but I am conducting analysis of the original data to be included in 
my thesis paper. There has been several publications on the data collected, two include 
“Pathways to Colonoscopy in the South: Seeds of Health Disparities” (Curbow et al, 
2015) and “It is just another test they want to do: Patient and caregiver understanding of 
the colonoscopy procedure” (King-Marshall et al, 2016). I received approval from the 
University of Maryland IRB to perform analysis on this data for my thesis paper (see 
appendix C). 
Study Sample 
Participants were recruited from patients who were scheduled for a colonoscopy 
at two academic-affiliated colonoscopy centers in Alachua County, Florida between 
September 2011 and October 2013. Eligible patients had to be able to read, write and 
comprehend English, and be cognitively able. Of the 3237 eligible patients, 737 of them 
were missed (22.8%) due to scheduling or patient flow issues. Of the remaining 2500 
patients, 1841 (73.6%) agreed to participate in the study (Curbow et al, 2015 and King-








A self-administered survey that contained 40 questions and took approximately 
15–20 minutes to complete was designed to provide information about the pre-
colonoscopy experience, refer to appendix B. There were four sections to this survey, 
with each section aimed at collecting a particular set of information about the patient. 
Part 1 covered information about how the patients were doing and how they expected the 
procedure to go. Part 2 collected information about the participant themselves, such as 
health literacy and what actions they would take to deal with having cancer. Part 3 
gathered specific information regarding who ordered the colonoscopy, why it was 
ordered and how it is being paid for. Part 4 asked about the patient’s health, perceived 
stress, tobacco use and supplement use. In the interest of time and to reduce patient and 
health system burden, patient demographic data was collected by a similar survey that 
was administered to the enrolled caregiver, refer to appendix C. 
Operationalization of Variables 
Health Outcome 
The health outcome, supplement use was assessed with a dichotomous variable 
(0=no and 1=yes). Participants marked whether they use any of the following every day 
or most days over the last six months: a. Multivitamin, b. Aspirin, c. Calcium, d. Vitamin 
C, e. Vitamin D, and h. Fish Oil. In relationship to supplement use, there are several 








There are several demographic variables that might be related to supplement use; 
they are age, gender, race, income, and education. Age was a numeric response originally 
coded as a continuous variable but recoded for this analysis as 1= ages 18-49, 2=50-64 
and 3= ages≥65 and gender is coded as 1=female and 2=male. Race was originally coded 
as follows: 1=American Indian/Alaskan Native, 2=Asian/Asian American, 
3=Black/African American, 4=Native Hawaiian/Pacific Islander, 5=White/Caucasian and 
6=Other but was recoded as follows for this analysis: 1=White/Caucasian, 
2=Black/African American, 3= all others. Income was coded for this analysis as 1 = less 
than (LT) $20,000, 2 = $20,000 to $49,999, 3 = $50,000 to $79,999, 4= greater than or 
equal to (GE) $80,000. Education was recoded as 1 = less than high school (0-11yrs), 2 = 
high school/GED (12yrs), 3=any college (13-15yrs), 4=college graduate (16yrs), 
5=graduate school (17yrs). 
Perceived Health Literacy 
Perceived health literacy was assessed using the BRIEF scale, which was adapted 
from the work of Chew, Bradley, and Boyko (2004) and Huan et al, (2009). The first item 
was ascertained by a Likert question: “how confident are you filling out medical forms by 
yourself?” (1=not at all to 5=extremely). The second item was ascertained by a Likert 
question: “how often do you have someone help you read medical materials?” (1=always 
to 5=never). The third item was ascertained similarly: “how often do you have problems 
learning about your medical condition because of difficulty understanding written 







“how often do you feel you don’t understand what the doctors tell you?” (1=always to 
5=never). The scale had good reliability (alpha = 0.75; mean inter-item correlation = 
0.43). Perceived health literacy score was the sum of the response of the four questions 
(range 4-20) but was recoded as low (4–15), medium (16-19) and high (20) (King-
Marshall et al, 2016). Informed about CRC was assessed on 1-5 Likert scale (1= not at all 
to 5= extremely) with the following question: “How informed about colon cancer and 
rectal cancer do you think you are?” 
Concern about CRC and Reason for Colonoscopy 
Concern about CRC was assessed on a 1–5 Likert scale (1 = not at all to 5 = 
extremely) with the following question: “how concerned are you about having colon or 
rectal cancer?” Reason for colonoscopy was assessed with the following question: “To 
the best of your knowledge, why was this colonoscopy ordered?” Responses were coded 
on a binary scale (1=yes and 2=no) with several response categories a. routine based on 
age, b. family history of colon cancer or rectal cancer, c. follow-up to a previous 
colonoscopy, d. follow-up to an abnormal test, and e. I have been having symptoms or 
problems. 
General Health 
Supplement use might be associated with general health. The health of the patient 
was measured in two separate ways. The first measurement of health dealt with the health 
status of the participant. The overall health of the participant was originally accessed on a 
1-6 Likert scale (1=excellent to 6=very poor) with the following question: “Would you 







and 3=poor) (BRFSS [CDC], 1993). The second measurement of health dealt with the 
physical and mental health of the participant. Physical health was accessed by a 
numerical response option with the following question: “Thinking about your physical 
health, which includes physical illness and injury, for how many days during the past 30 
days was your physical health not good?” (BRFSS [CDC], 1993) Mental health was also 
accessed by a numerical response option with the following question: “Thinking about 
your mental health, which includes stress, depression and problems with emotions, for 
how many days during the past 30 days was your mental health not good?” (BRFSS 
[CDC], 1993) After identifying the variables of interest, the data was cleaned. 
Data Cleaning 
In order to perform accurate data analysis, the data had to be cleaned. First, 
participants who did not answer supplement use questions (n=107) and participants who 
had age missing (n=7) were deleted from the analysis; some participants who did not 
answer supplement questions also had their age missing. Third, for individuals who had 
income missing, the data was left as missing. The final sample size (N) for the data after 
cleaning was 1756. 
New Variables 
Two new variables were created, any supplement, represented the use of any of 
the six supplements (multivitamin, calcium, vitamin C, vitamin D, fish oil and aspirin) by 
participants and protective supplement, which consists of supplements that have been 
shown to have a protective effect against CRC (Hoffmeister, 2007, Wactawski-Wende, 







aspirin, calcium and vitamin D use summed together. This variable was created to see if 
this population was using supplements that research has shown can benefit them.  
Analysis Plan 
The analysis plan was outlined in Table 2. Secondary analysis using IBM SPSS © 
for Windows version 21.0 was used to determine if there are any significant associations 
between supplement use and demographic variables (race, age, income and education), 
perceived health literacy, informed about CRC, concern about CRC, reason for 
colonoscopy, and general health. There was several supplement use variables: type of 
supplement use (each individual supplement), any supplement (use of any supplement) 
and protective supplement (use of the 3 protective supplements). First, univariate analysis 
was performed on all variables to obtain frequencies, mean and standard deviation. Next, 
bivariate analysis was conducted to analyze each variable in regard to the supplement use 
categories. Third, an ANOVA or chi-square test was performed to determine the 
association, if any exist between the variables.  
The first research question was to identify the rate of supplement use among this 
population and its association with different variables. Question 1.1 was to find the rates 
of supplement use (type of supplement use, any supplement use and protective 
supplement use). Question 1.2 was to determine if there is a relationship between 
demographic variables (age, gender, race, income, education) and all three supplement 
use variables. Question 1.3 was to determine if there is a relationship between perceived 
health literacy and informed about CRC and all three of the supplement use variables. 







reason for colonoscopy and the three supplement use variables. A chi-square test was 
used to analyze categorical variables in regard to the three supplement use variables. An 
ANOVA test was used to analyze continuous variables in regard to the three supplement 
use variables. 
The second research question was to compare general health and two of the 
supplement use variables (type of supplement uses and any supplement use). Question 
2.1 was to determine if there is an association between health status and two out of the 
three supplement use variables. Question 2.2 was to determine if physical health was 
associated with two supplement use variables. Question 2.3 was to determine if mental 
health was associated with two supplement use variables. A chi-square test was used to 
analyze health status in regard to two supplement use variables because all variables are 
categorical. ANOVA was used to analyze physical health and mental health sick days in 
regard to the two supplement use variables since they are continuous variables. 
Table 2: Analysis Plan 














1.1 What are the 
rates of supplement 
use? 
N/A ✓ ✓ ✓ Frequencies/ 
Descriptive 
1.2 Are demographic 
variables associated 
with supplement use? 
Age 
(continuous) 
✓ ✓ ✓ ANOVA 
Gender 
(categorical) 
✓ ✓ ✓ Chi-square 
Race 
(categorical) 





















1.2 Are demographic 
variables associated 
with supplement use? 
Income 
(categorical) 
✓ ✓ ✓ Chi-square 
Education 
(categorical) 
✓ ✓ ✓ Chi-square 
1.3 Are perceived 
health literacy and 














✓ ✓ ✓ Chi-square 
1.4 Are concern 












✓ ✓ ✓ Chi-square 
2.1 Is health status 
associated with 
supplement use? 
Health status  
(categorical) 
✓ ✓  Chi-square 






✓ ✓  ANOVA 






✓ ✓  ANOVA 
Table 2: Describes the supplement use variable that each variable will be analyzed against and the 








Chapter 4: Results 
Overview 
Univariate analysis was conducted to determine the frequencies, mean and 
standard deviation of all variables, refer to table 3. Bivariate analysis was then performed 
between each variable and the supplement use categories: an ANOVA or chi-square test 
was done to determine if any association exist between any of the variables and 
supplement use. Afterwards, a post hoc test was conducted to determine where the 
difference lies within the different categories of variables that were found to be 
significant. Adjusted residuals with Excel were used as a post-hoc analysis of chi-square 
test of independence, with bonferroni corrections of the P values; the adjusted p value 
was calculated by dividing the original p value (0.05) by the number of comparisons. 
The sample was predominantly White (77.3%), female (61.5%), and Non-
Hispanic (87.4%). In regards to income, participants were distributed about evenly across 
the 4 income categories (range ≤10,000 to ≥80,000). The average education level was 
14.2 years and the average age was 53.7 years, refer to Table 3. 
Table 3: Frequencies of Variables 
Demographics 
Variable Category 1756 (%) 
Race White 1306 (77.3) 
Black/ African American 250 (14.8) 
Other 134 (7.9) 
Age 18-49 467 (26.6) 







Variable Categories N (%) 
Age ≥65 359 (20.4) 
Gender Female 1070 (61.5) 
Male 671 (38.5) 
Income ˂$20,000 411 (26.9) 
$20,000-49,999 419 (27.5) 
$50,000-79,999 289 (18.9) 
≥$80,000 408 (26.7) 
Education Less than High School (0-11yrs) 97 (6.0) 
High School/GED (12yrs) 441 (27.3) 
Some College (13-15yrs) 419 (25.7) 
College Graduate (16yrs) 242 (15.1) 
Graduate School (17yrs) 418 (25.9) 
Perceived Health Literacy 
(Range 4-20) 
Low (4-15) 456 (27.7) 
Medium (16-19) 837 (50.8) 
High (20) 355 (21.5) 
Colorectal Cancer Variables 
Informed about CRC Not at all/Slightly 466 (27.0) 
Moderately 651 (37.7) 
Quite a lot/Extremely 610 (35.3) 
Concern about CRC Not at all 347 (20.2) 
Slightly 530 (30.7) 
Moderately 454 (26.3) 
Quite a lot/Extremely 394 (22.8) 
Reason for colonoscopy 
*these are not mutually exclusive 
Routine based on age 806 (49.6) 
Family history of CRC 331 (20.7) 
Follow-up to previous colonoscopy 465 (28.9) 
Follow-up to an abnormal test 234 (14.9) 
I have been having symptoms or problems 625 (38.9) 







Variable Categories N (%) 
Health Status Very Good 821 (50.4) 
Good  572 (35.1) 
Poor 237 (14.5) 
Physical Health 
(Mean/ Standard Deviation) 
# of days not good 6.34±10.01 
Mental Health 
(Mean/ Standard Deviation) 
# days not good 5.19±9.12 
Supplement Use 
*these are not mutually exclusive 
Multivitamin 834 (48.4) 
Calcium 472 (27.9) 
Vitamin C 379 (22.7) 
Variable Categories N (%) 
Supplement Use Vitamin D 575 (34.0) 
Fish Oil  398 (23.4) 
Aspirin 548 (32.4) 
Any Supplement Use 
(Multivitamin, Aspirin, Calcium, 
Vitamin C, Vitamin D, Fish Oil) 
Used none 517 (31.8) 
Used one 367 (22.5) 
Used two 247 (15.2) 
Used three or more 497 (30.5) 
Protective Supplement Use 
(Aspirin, Calcium, vitamin, 
Vitamin D) 
Use none 775 (47.0) 
Used one 416 (25.2) 
Used two 303 (18.4) 
Used three 155 (9.4) 
Table 3: Univaritae Analysis of variables that display the frequency, sample size, mean and standard 
deviation, along with the categories of each variable. 
Rate of Supplement Use 
As shown in Table 4, supplement use was categorized into three separate 
variables (type of supplement use, any supplement use and protective supplement use). 







above. Multivitamins were used most often by participants (48%), followed by vitamin D 
(34%), aspirin (32%), calcium (27%), fish oil (23%) and vitamin C (22%). Any 
supplement use was defined as the use of none (31.8%) vs. one (22.5%) vs. two (15.2%) 
vs. three or more (30.5) of the six supplements. Similarly, protective supplement use was 
defined as the use of none vs. one vs. two vs. three of the protective supplements 
(calcium, aspirin and vitamin D). Among this population, 47.0% of supplement users 
took no protective supplements, 25.2% took one, 18.4% took two and 9.4% took three or 
more. A chi-square test or ANOVA was performed to examine the association between 
several variables and supplement use (type of supplement use, any supplement use and 
protective supplement use). An alpha level of 0.05 was used for both statistical tests. 
Table 4: Supplement Use Analysis 
1.1 What is the rate of supplement use (type of supplement use, any supplement use and protective 
supplement use)? 






















Table 4: Univariate Analysis of each type of supplement use, any supplement use and protective 
supplement use was conducted, frequencies provided. 
Demographics 
Age Categorical 
For the purpose of this analysis, age was broken into three categories ages 18-49 
(27%), 50-64 (53%) and 65 and older (20%), refer to Table 5.1. The relationship between 
age and type of supplement was significant. Older participants (62%) were more likely to 







ages 18-49 (40%). There were similar results for aspirin X2 (2, N=1693)= 144.93, p<.001 
and calcium X2 (2, N=1689)= 46.47, p<.001. Older participants were more likely to use 
aspirin (54.3%) compared to those ages 50-64 (33.1%) and those ages 18-50 (14.2%). 
Older participants were also more likely to use calcium (40.1%) compared to those ages 
50-64 (28.3%) and those ages 18-49 (18.2%). The results were the same for vitamin C X2 
(2, N=1671)= 12.37, p=.02, vitamin D X2 (2, N=1690)= 55.05, p<.001 and fish oil X2 (2, 
N=1685)= 74.97, p<.001.  The oldest participants (ages 65 and older) were using these 
supplements more than the younger participants (ages 18-49 and 50-64), refer to Table 
5.1 
There was a significant association between age and any supplement use X2 (6, 
N=1628)= 120.52, p≤.001. The youngest participants were more likely to be using no 
supplements (44.6%) when compared to the older participants’ ages 50-64 (32.1%) and 
ages 65 and older (13.2%). On the other hand, older participants were more likely to be 
using 3 or more supplements (49.4%) compared to younger participants ages 50-64 
(29.4%) and ages 18-49 (19%). Similarly, there was a significant association between age 
and protective supplement use X2 (6, N=1649)= 155.37, p≤.001. Participants ages 18-49 
were more likely to use no protective supplements (64.4%) compared to participants ages 
50-64 (46.9%, p<.001) and ages 65 and older (23.8%, p≤.001). Moreover ages 65+ were 
more likely to use at least 2 protective supplements (29.5%) compared to the other two 
groups (18-49-p≤.001 and 50-64-p<.001). Similarly, participants 65 and older were also 
more likely to use three protective supplements (19.0%) compared to those ages 50-64 








Analysis using continues age data (range: 18-87, mean and SD: 53.8± 12.8) 
showed similar trends. An analysis of variance showed a significant association between 
age continuous and type of supplement use: multivitamin F (66, 1656)= 1.58, p=.002, 
aspirin F (66, 1626)= 4.02, p<.001, calcium F (67, 1621)= 1.71, p<.001, vitamin D F 
(67, 1622)= 1.79, p<.001, and fish oil F (67, 16170= 1.98, p<.001). However, age 
continuous was not significantly associated with vitamin C (p=.195). Older age was 
found to be significantly associated with increased any supplement use F (3, 1624)= 47. 
36, p<.001 and increased protective supplement use F (66, 1582)=3.48, p<.001; refer to 
Table 5.1. Older participants were more likely to be using more supplement s and also 
protective supplements. 
Gender 
A chi-square test of independence was performed to examine the relationship 
between gender and type of supplement use, refer to table 5.1. The relationship between 
these variables was significant for calcium X2 (1, N=1679)= 73.39 , p<.001, vitamin D 
X2 (1, N=1679)= 53.98, p<.001 and aspirin X2 (1, N=1681)= 17.71, p<.001. Females 
were more likely to use calcium (35.2% vs. 15.9%) and vitamin D (40.6% vs. 23.1%) 
compared to males. However males (38.4%) were more likely than females (28.5%) to 
use aspirin. The relationships between gender and multivitamin (p<=.442), vitamin 
(p=.383), or fish oil (=.458) were not significant. Females and males were equally likely 







Any supplement use was found to be associated with gender, X2 (3, 
N=1691)=  38.70, (p=.004). Females are more likely to use three or more supplements 
(32.7%) compared to males (26.9%). Likewise, protective supplement use was found to 
be associated with gender, X2 (3, N=1639)=  37.55, p<.001. Females were more likely to 
be using two protective supplements (21.7%) compared to males (13.0%), refer to Table 
5.1. 
Race 
For analysis purposes, race was condensed into three groups: Whites (77%), 
Blacks (15%) and others (8%). The relationship between race and five of the six 
supplements were significant as shown in table 5.1. Compared to Whites (49.6%) and 
other races (51.89%), Blacks (38.5%) were significantly less likely to use 
multivitamin  X2 (2, N=1660)= 11.12, p=.004. The same was true for calcium X2 (2, 
N=1631)= 18.68, p<.001 and fish oil X2 (2, N=1630)= 13.54, p=001. Furthermore, 
Whites (33.6%) and Blacks (30.6%) were more likely to use aspirin X2 (2, N=1636)= 
6.38, p=.041 compared to the other races (23.1%) [p=0.035 and p=0.027 respectively]. 
Additionally, Whites were more likely to consume vitamin D X2 (2, N=1631)= 6.64, 
p=.036 (35.3%), compared to Blacks (27.6) and other races (29.2%) (p=0.024 and 
p=0.041 respectively). On the other hand, there was no significant association between 
race and vitamin C (p=.164); refer to Table 5.1. 
A significant association was found between any supplement use and race,  X2 
(6, N=1575)= 17.06, p=.009. Whites and other races were more likely to be using three or 







association was also found between protective supplement use and race, X2 (6, N= 
1594)= 15.0, p=.020. 
Table 5.1: Age, Gender and Race Analysis 
1.2 How is this rate associated with age, gender, race? 
 












<.001 <.001 <.001 0.002 <.001 <.001 <.001 <.001 
18-49 
% yes 






























.002 <.001 <.001 0.195 <.001 <.001 <.001 <.001 










0.442 <.001 <.001 0.383 <.001 0.458 .004 <.001 
Female 
% yes 




















0.004 0.041 <.001 0.164 0.036 0.001 .009 0.020 
White 
% yes 
49.6 33.6 29.8 22.9 35.3 25.7 None:30.7 
One: 21.8 
Two: 14.8 
>3 : 32.8 
None:45.2 





38.5 30.6 16.3 18.2 27.6 14.8 None:38.0 
One: 25.3 
Two: 16.9 















Table 5.1: Bivariate analysis of supplement use by demographic variables (age, gender and race) was 








Income was condensed into four categories: <$20K (27%), $20K-49,999 (28%), 
50K-79,999 (19%) and ≥80K (26%) for the purpose of this analysis, refer to table 5.2. A 
chi-square test of independence was performed to examine the relationship between 
income and type of supplement use. A significant association was found between these 
variables. The relationship was significant for calcium X2 (3, N=1476)= 21.12, p<.001; 
analysis showed that participants who had an income between $50K-79,999 were more 
likely to use calcium (38.2%), compared to those who income was <$20K (22.9%), 
between $20K-49,999 (25.4%) or >$80K (28.6%). The results were very similar for 
vitamin C X2 (3, N=1463)= 13.71, p=.003. Furthermore, the relationship was significant 
for multivitamin X2 (3, N=1503)= 21.63, p<.001; those participants who had an income 
between $50K-79,999 (57.2%) and  participants who had an income ≥$80K (51.5%) 
were more likely to use multivitamins, compared to those whose income was either 
between $20K-49,999 (44.2%) or <$20K (41.2%). Similar results were found for fish oil 
X2 (3, N=1473)= 28.41, p<.001. Additionally, there was no significant association for 
aspirin (p=.138) or vitamin D (p=.051) with income; refer to Table 5.2 
Regarding each income category, there was a significant association with any 
supplement use X2 (9, N=1425)= 22.32, p=.008); those with higher income were more 
likely to be using three or more supplements (30.2%-37.0%) compared those with lower 
incomes (24.1%). Similarly, for each income category, there was a significant difference 
between the number of protective supplements that participants use .X2 (9, N=1441)= 
21.08, p=.012. Participants in the highest income category (>$80K) were more likely to 







an income between 50K and 79,999 were the least likely not to use supplements (40.1%) 
compared to those with an income <20K (52.8%), 20K-49,999 (47.7%) or >80K (48.3%). 
Education 
As seen in table 5.2, for the purpose of this analysis education was split into five 
categories: less than high school (0-11 yrs)-6.0%, high school/GED (12yrs)-27.0%, some 
college (13-15yrs)-26.0%, college graduate (16yrs)-15.0% and graduate school (17yrs)-
26.0%). Analysis showed a significant association between education and type of 
supplement use. Compared to those who completed college or graduate school (16 or 17 
years of school), participants who completed less than 16-17 years of school were less 
likely to use certain supplements: multivitamins X2 (4, N=1589)= 13.99, p=.007, 
vitamin D X2 (4, N=1561)= 12.51, p=.014, and fish oil X2 (4, N=1560)= 11.05, p=.026. 
However, there was no significant association between education and aspirin (p=.639), 
calcium (p=.230), or vitamin C (p=.210); refer to Table 5.2. 
Furthermore, there was a significant association between education and any 
supplement use X2 (9, N=1507)= 22.21, p=.035. Participants with less education (grades 
0=11yrs) were less likely to use three or more supplements (22.8%) compared to those 
who completed high school (28.6%), some college (30.6%), college (31.3%) and 
graduate school (33.3%). However, the association between education and protective 









Table 5.2: Income and Education Analysis 
1.2 How is this rate associated with income and education? 











Income <.001 0.138 <.001 0.003 0.051 <.001 .008 0.012 
>20K 
% yes 











44.2 28.9 25.4 21.3 34.3 20.1 None:33.0 
One: 23.5 
Two: 13.3 


























Education 0.007 0.639 0.230 0.210 0.014 0.026 .035 0.540 
Less than 
high school  
% yes 























47.3 32.2 27.5 21.6 36.8 21.3 None:32.5 




One:  23.9 





52.7 31.1 29.5 24.7 35.6 25.5 None:27.8 
One:  24.7 
Two:  16.3 
≥3: 31.3 
None:45.5 
One:  27.3 





52.5 32.4 31.8 25.2 37.1 28.6 None:29.7 
One: 18.9 




Two:  19.8 
Three:10.9 
Table 5.2: Bivariate Analysis of supplement use by demographic variables (income and education) was 







Perceived Health Literacy 
Categorical 
For analysis purposes, perceived health literacy was condensed into three 
categories [low (4-14), medium (16-19) and high (20)], based on the combined score of 
four questions. There was no significant association between low, medium, or high 
perceived health literacy and supplement use. This was consistent for all three analyses 
(type of supplement use, any supplement use and protective supplement use); p values 
ranged from 0.162 to 0.660, refer to Table 7. 
Continuous 
As shown in Table 7, perceived health literacy continuous (range: 5-20, mean and 
SD:16.9±3.0) was only significantly associated with multivitamin F (66, 1656)= 1.58, 
p=.002. Participants with higher perceived health literacy were more likely to report 
using multivitamins. However, there was no significant association with the other 
supplements, any supplement use or protective supplement use (p values ranged from 
.061-.958). 
Informed about CRC 
Informed about CRC was further condensed into three categories [not at 
all/slightly (27%), moderately (38%), and quite a lot/extremely (35%)] for analysis 
purposes, refer to table 7. Being informed about CRC was significantly associated with 
each type of supplement: multivitamin X2 (2, N= 1696)= 22.07, p<.001, calcium X2 (2, 







N= 1667)= 42.06, p<.001 and fish oil  X2 (2, N= 1666)=26.17, p<.001. Those who were 
quite a lot/extremely or moderately informed about CRC were more likely to use these 
supplements compared to those were not at all/slightly informed about CRC or less 
informed about CRC. However, aspirin use did not have a significant association with 
being informed about CRC (p=.485), refer to Table 6. 
Any supplement use was found to be associated with being informed about CRC 
X2 (6, N=1609)= 39.47, p<.001.There was no difference between the groups with those 
using one or two supplements. However, those who were quite a lot/extremely (36.7%) or 
moderately (31.5%) informed about were more likely to be using 3 or more supplements 
compared to those who were not at all/slightly (21.1%) informed about CRC. Similarly, 
protective supplement use was also shown to be significantly associated with being 
informed about CRC X2 (6, N=1629)= 46.85, p<.001. There was no difference among the 
groups with those using one or at least three protective supplements. However, those who 
were quite a lot/extremely informed about CRC (25.7%) were more likely use two 
protective supplements, compared to those who were not at all/slightly informed about 
CRC (11.6%) and those moderately informed about CRC (16.6%). 
Table 6: Perceived Health Literacy and Informed about CRC Analysis 
1.3 How is this rate associated with perceived health literacy and informed about CRC? 















0.162 0.261 0.455 0.481 0.202 0.292 .349 0.660 
Low (4-15) 
% yes 
45.0 35.2 26.2 21.9 31.0 22.2 None:30.0 
One:  26.3 
Two:  13.7 
≥3:30.0 
None:45.7 
One:  27.9 























48.8 31.1 29.1 24.2 35.7 24.1 None:32.1 
One:  21.4 
Two:  15.0 
≥3: 31.5 
None:47.8 
One:  22.9 
















0.003 0.748 0.367 0.802 0.183 0.577 .113 0.564 
mean 17.1 16.6 17.0 16.9 17.1 17.0 None:16.9 













39.4 31.0 19.0 16.0 23.6 15.4 None:39.4 
One:  26.1 
Two:  13.3 
≥3:21.1 
None:55.5 
One:  26.1 




49.3 31.3 28.3 23.2 
 
32.7 24.7 None:31.7 
One:  21.5 
Two:  15.3 
≥3:31.5 
None:48.2 
One:  25.2 
Two:  16.6 
Three:10.1 
Quite a lot/ 
extremely 
% yes 








Table 6: Bivariate Analysis of supplement use by perceived health literacy and Informed about CRC was 
conducted, p values provided and percent of participants who selected yes. 
Concern about CRC 
Being concern about CRC was only found to be associated with aspirin X2 (3, 
N=1669)= 15.25, p=.002. Participants who were quite a lot/extremely (35.9%) or 
moderately (37.2%) were more likely to use aspirin, compared to those who were slightly 
(28.8%) or not at all (26.4%) informed about CRC. On the other hand, there was no 
association between concern about CRC and multivitamin (p=.687), calcium (p=.484), 
vitamin C (p=.055), vitamin D (p=.202), or fish oil (p=.224). Similarly, there was no 
association between concern about CRC and any supplement use (p=.059) or protective 







Table 7: Concern about CRC Analysis 
1.4 How is this rate associated with concern about CRC? 














0.687 0.002 0.484 0.055 0.202 0.224 .059 0.154 
Not at all  
% yes 
48.8 26.4 29.6 25.2 35.2 23.3 None:34.7 
One:  19.1 
Two:  17.2 
≥3:291 
None:50.9 
One:  22.2 




46.6 28.8 25.4 18.4 30.4 21.6 None:33.8 
One:  25.7 
Two:  15.1 
≥3:255 
None:51.2 
One:  25.1 




50.3 37.2 29.0 24.8 33.9 27.2 None:28.4 
One:  23.0 
Two:  14.3 
≥3:343 
None:43.6 
One:  26.5 
Two:  19.5 
Three:104 
Quite a lot/ 
Extremely 
% yes 
48.1 35.9 28.5 23.1 36.9 22.8 None:30.5 
One:  20.5 
Two:  15.1 
≥3:338 
None:42.8 
One:  25.7 
Two:  21.4 
Three:10.2 
Table 7: Bivariate Analysis of supplement use by concern about CRC was conducted, p values provided and percent of 
participants who selected yes. 
Reason for Colonoscopy 
Participants answered a series of yes/no statements related to their perceived 
reasons for their current colonoscopy. The reasons included routine based on age 
(49.6%), family history of CRC (20.7%), follow-up to an abnormal test (14.9%), follow-
up to previous colonoscopy (28.9%) and patient reported symptoms and problems 
(38.9%). The response options were not mutually exclusive; therefore participants may 
have selected more than one reason for why the colonoscopy was ordered. 
Routine based on age 
The association between routine based on age and type of supplement use was 
significant for aspirin X2 (1, N= 1579)= 27.21, p<.001 and fish oil X2 (1, N= 1573)= 







likely to be using aspirin and fish oil. However, there was no significant association was 
for multivitamin (p=.060), calcium (p=.141), vitamin C (p=.654) or vitamin D (p=.369). 
Likewise, there was no significant association between routine based on age and 
any supplement use (p=.481). However, there was a significant association with 
protective supplement use X2 (3, N= 1543)= 13.06, p=.005. Participants who reported 
routine based on age as the reason for the colonoscopy were using less protective 
supplements; 45.6% used no protective supplements compared to those using one 
(26.2%) or two (17.0%) or three (11.2%), refer to Table 8. 
Family history of CRC 
Chi-square analysis showed no association between family history of CRC and 
each type of supplement use, except for calcium X2 (1, N=1554)= 4.42, p=.036. Of those 
who selected family history of CRC, 31.5 % used calcium compared to 68.5% who did 
not use calcium. There were no significant association with any supplement use (p=.913) 
or protective supplement use (p=.085), refer to Table 8. 
Follow-up to previous colonoscopy 
The association between follow-up to a previous colonoscopy and type of 
supplement use is significant: multivitamin X2 (1, N= 1589)= 8.79, p=.003, aspirin X2 
(1, N= 1568)= 10.19, p=.001, calcium X2 (1, N= 1567)= 14.71, p<.001, vitamin D X2 (1, 
N= 1568)= 22.16, p<.001 and  fish oil X2 (1, N= 1569)= 15.79, p<.001. For those who 
selected follow-up to previous colonoscopy, they were more likely to have used the 
supplements listed above, compared to those who did not select this option. Moreover, 







Additional analysis showed a significant association between follow-up to a 
previous colonoscopy and any supplement use X2 (3, N=1520)= 25.62, p<.001. 
Participants who selected follow-up to previous colonoscopy were more likely to use 
three supplements (38.7%) compared to those who did not select this option (26.3%). 
Likewise, there is a significant association with protective supplement use X2 (3, 
N=1539)= 28.55, p<.001.  Participants who selected follow-up to previous colonoscopy 
were more likely to use two protective supplements (24.4%) compared to those who did 
not select this option (16.4%). 
Follow-up to an abnormal test 
As shown in table 8, the association between follow-up to an abnormal test and 
supplement use analyses was not significant. The association between follow-up to an 
abnormal test and type of supplement use was non-significant for multivitamin (p=.809), 
aspirin (p=.747), calcium (p=.339), vitamin C (p=.556), vitamin D (p=.683), or fish oil 
(p=.486). Likewise, additional analysis showed no significant association with any 
supplement use (p=.540) or protective supplement use ( p=.575); refer to Table 8. 
I have been having symptoms or problems 
The association between having symptoms or problems and type of supplement 
use is significant for aspirin X2 (1, N=1564)= 30.54, p<.001. Those who were there 
because they were having symptoms were less likely to use aspirin (23.3%) compared no 
those not there because they were having symptoms (36.6%). However, the association 
was not significant for multivitamin (p=.359), calcium (p=.302), vitamin C (p=.602), 







Additional analysis showed a significant association between a person having 
symptoms or problems and both any supplement use X2 (3, N= 1519)= 8.29, p<.001 and 
protective supplement use X2 (3, N= 1539)= 18.92, p<.001. Participants were less likely 
to have used supplements; 35.7% used none, 21.2% used one, 15.6% used two, and 
27.6% use three or more. Likewise, participants were also less likely to have used 
protective supplements; 52.9% used none, 22.0% use one, 18.8% used two and 6.2% use 
three or more. 
Table 8: Reason for Colonoscopy Analysis 
1.4 How is this rate associated with reason for colonoscopy? 
 

















0.064 <.001 0.141 0.654 0.369 0.031 .481 0.005 
% yes 50.3 38.1 29.0 21.9 31.9 25.1 None:  29.6 
One:  23.6 
Two:  16.1 
≥3:30.8 
None: 45.6 
One:  26.2 





0.578 0.483 0.036 0.295 0.052 0.150 .913 0.085 
% yes 45.9 32.9 31.5 24.1 37.3 19.4 None:29.9 
One:  23.2 
Two:  16.6 
≥3:30.3 
None:44.0 
One:  23.3 





0.003 0.001 <.001 0.183 <.001 <.001 <.001 <.001 
% yes 53.6 37.4 33.9 24.3 41.7 29.7 None:24.9 
One:  22.6 
Two:  13.8 
≥3:38.7 
None:37.4 
One:  26.9 






0.809 0.747 0.339 0.556 0.683 0.486 .540 0.575 
% yes 47.0 30.4 24.2 20.5 31.3 24.3 None:33.6 
One:  21.7 

































% yes 46.1 23.3 25.7 22.8 32.5 19.9 None:35.7 
One: 21.2 
Two:  15.6 
≥3:27.6 
None: 52.9 
One:  22.0 
Two:  18.8 
Three: 6.2 
Table 8: Bivariate analysis of supplement use by the five reasons for the colonoscopy was conducted, p 
values provided and percent of participants who selected yes. 
General Health 
Health Status 
For the purpose of this analysis, health status was condensed in three categories: 
very good (50.4%), good (35.1%) and poor (14.5%), refer to Table 9. Only multivitamin 
had a significant association with health status X2 (2, N=1602)= 6.14, p=.047. Those who 
had very good (50.2%) or good (47.6%) health status were more likely to use 
multivitamins than those with a poor health status (41.0%). The analysis did not show 
any significant association between health status and the other supplements; aspirin, 
calcium, vitamin C, vitamin D or fish oil; p values ranged form .080-.761). Similarly, 
there was no significant association between health status and any supplement use 
(p=.447). 
Table 9: Health Status Analysis 
2.1 How is health status associated with supplement use? 

















50.2 31.0 29.9 22.3 33.6 24.4 None:  32.2 
One:  22.3 























47.6 33.6 27.5 24.3 35.3 22.9 None:  30.8 
One:  21.7 





41.0 33.2 22.6 19.7 33.2 17.3 None:  34.5 
One:  26.1 
Two:  13.3 
≥3: 26.1 
N/A 
Table 9: Bivariate analysis of supplement use by health status was conducted, p values provided and percent of 
participants who selected yes. 
Physical Health 
Participants were asked the number of days their physical health was not good, 
this ranged from 0-30 days and the mean was 6.34. Physical health was only significantly 
associated with multivitamin use F (31, 1636)= 1.64, p=.015, refer to Table 10. 
Participants who did not use multivitamins had a greater mean number of days that their 
physical health was not good. However, physical health was not found to be associated 
with any supplement use, p values ranged from 6.08-7.46, refer to table 10. 
Table 10: Physical Heath Analysis 
2.2 How is physical health associated with supplement use? 




















0.015 0.117 0.314 0.554 0.833 0.15
6 
.051 N/A 
mean 5.5 5.9 5.4 6.6 6.3 5.0 None: 7.46 
One:  6.08 
Two:  5.42 
≥3: 6.42 
N/A 
Table 10: Bivariate analysis of supplement use by physical health was conducted, p values provided and 
percent of participants who selected yes 
Mental Health 
Participants were asked the number of days their mental health was not good, this 







between mental health and any individual supplement. This held true for any supplement 
use, p values ranged from 0.085-0.885, refer to table 11. 
Table 11: Mental Health Analysis 
2.3 How is mental health associated with supplement use? 














0.349 0.085 0.885 0.590 0.521 0.605 .136 N/A 






Table 11: Bivariate analysis of supplement use by mental health, p values were provided and percent of 







Chapter 5:  Discussion 
 
Summary of Central Finding 
The purpose of this paper was to determine if any associations exist between 
supplement use and several variables of interest. Supplement use was defined in three 
ways: type of supplement use, any supplement use and protective supplement use. Two 
research questions pertaining to supplement use were examined: (1) Among a group of 
pre-colonoscopy individuals, how do rates of supplement use differ by various 
demographic and conceptual characteristics? and (2) Among a group of pre-colonoscopy 
individuals, is general health associated with supplement use? The simple answer to each 
question is yes- demographic and conceptual characteristics are associated with 
supplement use. The data showed that older participants, females, Whites, those with 
higher income and education were more likely to use supplements. These results were 
similar to the national statistics (NHANES 30124) in the general population (CDC, 
2016). Similarly, informed about CRC and reason for colonoscopy were found to be 
significant with supplement use. The variables that were most significant with 
supplement use were the demographic variables and informed about CRC. 
 Previous research has similarly found age to be associated with supplement use, 
with the older population (age 60 and older) being more likely to use supplements 
(Gahche et al, 2017). This was consistent with the findings of the present study, as those 
65 and older were more likely to use supplements compared to those ages 18-49 and 
those ages 50-64. A longitudinal study investigating supplement use among a Japanese 







al, 2015). This was consistent with the finding in this paper that demonstrated that gender 
was associated with supplement use, with females using supplements more than males. 
Similarly, race was found to be associated with supplement use; whites and other races 
were more likely to use certain supplements compared to Blacks. This was illustrated in a 
study among an urban African American and White population which showed that 
Whites used calcium, magnesium, niacin, and riboflavin more than their African 
American counterparts (Stave, 2015). Similarly, other races use certain supplements, such 
as vitamin A, vitamin B and magnesium, more than Blacks (Blumberg, 2017). The 
relationship between income and supplement was supported, in a study (Whiting, et al, 
2010) which demonstrated that lower income individuals were less likely to use 
supplements. Among a study evaluating supplement use among Black and Whites, results 
illustrated that that participants who had literacy of college level or higher were more 
likely to use supplements (Stave, 2015). This was consistent with findings of this analysis 
that showed that participants with high education (college graduate or graduate school) 
were more likely to use supplements compared to those with low education (less than 
high school, some high school and some college). In addition to demographic factors, the 
results showed that being informed about CRC was significantly associated with 
supplement use. Those who were informed about CRC were more likely to be using 
supplements. 
 However, reason for colonoscopy, concern about CRC and perceived health 
literacy were not associated with supplement use. To my knowledge, there have not been 
prior studies examining why a colonoscopy was ordered and its association with 







and perceived health literacy and their relationship with supplement use. General health 
was not found to be associated with supplement use; this was interesting since studies 
have shown that supplement use was associated with living a healthier life, decreasing 
smoking and alcohol use, having a healthy diet and exercising often (Hoggatt, 2003, 
Bailey et al, 2007). 
Implication of Findings 
The results pertaining to demographics among this population were similar to 
those found in the literature (Council for Responsible Nutrition, 2012). The data shows 
that among supplement users, white women with high education and income are more 
likely to use supplements compared to other groups. Therefore other groups, such as the 
younger population, males, minorities, and those with lower education and income, are 
missing out on the potential benefits they could acquire from taking supplements (ODS, 
2018). Despite the health benefits that supplements can produce, disparities exist in 
supplement use; populations may have barriers that prevent them from using supplements 
or there might be a lack of awareness about supplements among these subgroups. 
Researchers must first determine if these subpopulations are obtaining the proper 
nutrients and if they are not, then they must identify the reasons why. Moreover, for those 
sub populations that are taking supplements, it is crucial that these individuals are not 
over consuming (Data and Vitolins, 2016). 
It was interesting to see that those individuals who have had a previous 
colonoscopy were less likely to be using all supplements except (vitamin C) compared to 
those who were not there for a previous colonoscopy. Screening events can be a great 







method to reduce their risk of CRC. Health providers can explain how supplements 
should be used and the potential benefits they can receive form using supplements, if they 
are a good candidate. This highlights the importance for more awareness about 
prevention strategies and the role that health care providers play in providing beneficial 
information to their patient.  
Limitations and Strengths 
There were several limitations of this study. First, geographic diversity did not 
exist since participants were recruited from rural-suburban areas and both sites were 
academic affiliated so there was no representation from urban patients or private 
practices. Second, there was a lack of racial diversity, most participants were either White 
or Black; there is lack of representation from other racial groups such as Asians and 
Native Americans. Third, the survey used did not have specific questions pertaining to 
supplement use, such as how long they had been taking the supplement (s) and what 
prompted them to begin using the supplement(s). However, these limitations are balanced 
by several strengths. First, this paper is a strong contribution to the scientific literature in 
a new area. There are few studies on supplement use among this population; this paper 
highlights potential factors that are associated with supplement use. Second, the survey 
allowed for the development of two research questions, with several sub questions that 
were analyzed rigorously by chi-square and t-test. Third, the study had a high response 
rate. The higher the response rate of a survey, the lower the risk of having non-response 
bias. Lastly, the study had a relatively large sample size (N=1756). This creates a 
narrower margin of error: the chance that the confidence interval (margin of error around 







size also increases the power of the statistical significance test and the decreases the 
probability of making a Type II error (incorrectly retaining a false null hypothesis). The 
findings are suggestive for future research and potential interventions. 
Directions for future Research 
Supplement use among this population was varied by several characteristics/ 
qualities. Similar to previous findings (Jasti et al, 2003) results showed that disparities 
exist in supplement use. Future research should focus on explaining why these disparities 
exist. Researchers need to (1) conduct a study to identify groups using and not using 
supplements; (2) identify facilitating factors and barriers to the utilization of supplement 
and (3) develop interventions where people can overcome those barriers and have equal 
opportunity for utilization. 
First there needs to be an assessment of those using and those not using 
supplements. This will help us to determine which populations we need to target to 
increase knowledge and awareness of supplements use. It is also important to understand 
which groups are taking supplements and the underlying reasons why. This can help use 
to understand why disparities exist in supplement use. Has supplement use been 
recommended to these groups by a health care provider? Furthermore, some individuals 
maybe taking supplements without the advice of their health provider; there can be 
negative side effects if they are taking medications or have a medical problem (ODS, 
2017).  It is also essential to identify groups that are not taking supplements because there 
are potential benefits they can receive from using supplements, if they are a good 
candidate. After identifying groups that use and do not use supplements, it is crucial to 







 Second, future research needs to focus on factors that facilitate or hinder the use 
of supplements among these populations. A large percent of the American population use 
supplements, but we need to understand the motivation to use these supplements and the 
channels that allow them access. However, there are sub-populations that do not use 
supplements. It is crucial that researchers investigate the barriers that prevent the use of 
supplements among these populations. Moreover, supplement use cannot be analyzed in a 
vacuum because it is just one of many strategies people utilize to improve their health 
and wellness (Dickinson, 2012).  
Third, for the supplements that are effective, how can we persuade those not using 
them to consume them? One solution is to get researchers to develop interventions. 
Tailored interventions can be designed among the populations that are not using 
supplements; these interventions can address the underlying reasons why people do not 
use supplements and the barriers they face. These interventions can increase awareness of 
supplements and knowledge of how and why supplements should be used. 
 Overall, the study findings suggest further research is needed to better understand 
the associations identified between the variables of interest and supplement use. Once 
researchers more fully understand the relationship between these variables, the findings 
can be used to develop, implement, and evaluate targeted interventions. Overall, these 
findings are a step towards a better understanding of supplement use among this pre-
colonoscopy population. 
Conclusion 
 Supplements have been shown to produce several health benefits and should be 







to the scientific literature regarding supplement use. Supplement use was found to be 
associated with demographic factors (age, gender, race, income and education) and being 
informed about CRC. However, supplement use was not found to be associated with 
perceived health literacy, concern about CRC and general health. The findings suggest 
that there are disparities in supplement use, which is consistent with the literature (Jasti et 
al, 2003; Foote, 2003; Blumberg, 2017; Stave, 2015; Whiting, 2017). Researchers need to 
focus on understanding the underlying factors that create disparities in supplement use 
among certain populations. There also needs to be more awareness and education about 
supplements, so individuals are obtaining proper amount of nutrients. Lastly, it is 
important to get health care providers involved in the process, they are a vital part of 










A. Table 12: Recoding of Variables 
 
Variable Original 1756 (%) Recode 1756 (%) 
Race 1=American Indian/ 
Alaskan Native  















5=White/Caucasian 1306 (77.3) 3=Other 134 (7.9) 
 
6=Other 70 (4.1) 
Age 53.8 (12.8) 1=18-49 467 (26.6) 
2=50-64  930 (53.0) 
3=≥65    359 (20.4) 
Gender 1=female 1070 (61.5) None 
2=male 671 (38.5) 
Income 1≤$10,000  225 (14.7) 1≤$20,000  411 (26.9) 
2=$10,000-19,999 186 (12.2) 2=$20,000-49,999  419 (27.5) 
3=$20,000-29,999 157 (10.3) 3=$50,000-79,999  289 (18.9) 
4=$30,000-39,999 149 (9.8) 4=≥$80,000   408 (26.7) 
5=$40,000-49,999 113 (7.4)  
6=$50,000-59,999 107 (7.0)  
7=$60,000-69,999 101 (6.6)  
8=$70,000-79,999 81 (5.3)  




16.9±3.0 Low (4-15) 456 (27.7) 
Medium  (15-19) 837 (50.8) 







Education 14.2±2.3 1= Less than High 
School (0-11yrs)  
97 (6.0) 




 3= Some College(13-
15yrs)  
419 (25.9) 
 4= College Graduate 
(16yrs)  
242 (15.1) 









 Slightly 330 (19.10 
 Moderately 651 (37.7) Moderately 651 (37.7) 
 
 Quite a lot 433 (25.1) 
 






Not at all 347 (20.1) Not at all 347 (20.1) 
Slightly 530 (30.7) Slightly 530 (30.7) 
Moderately 454 (26.3) Moderately 454 (26.3) 
Quite a lot 226 (13.1) Quite a lot/ 
Extremely 
394 (22.8) 
 Extremely 168 (9.7) 
Reason for 
Colonoscopy 
*these are not 
mutually exclusive 
Routine based on age 806 (49.6) None 
Family history of colon or 
rectal cancer 
331 (20.7) 
Follow-up to previous 
colonoscopy 
465 (28.9) 
Follow-up to an abnormal 
test 
234 (14.9) 
I have been having 
symptoms or problems 
625 (38.9) 
Health Status 1=Excellent  273(16.8) 1=Excellent +Very 
Good Very Good 
 
821 (50.4) 
 2=Very Good  548 (33.6) 







 4=Fair  183 (11.2) 
 5=Poor  51 (3.1) 3=Fair+ Poor+ Very 
Poor Poor 
237 (14.5) 
 6=Very Poor  3 (0.2) 
Physical Health 6.34±10.01 None 
Mental Health 5.19±9.12 None 
Supplement Use 
*these are not 
mutually exclusive 
Multivitamins 834 (48.4) Use none 517 (31.8) 
Calcium 472 (27.9) Use one 367 (22.5) 
Vitamin C 379 (22.7) Use two 247 (15.2) 
Vitamin D 575 (34.0) Use three or more 497 (30.5) 
Fish Oil 398 (23.36)   





N/A Used none 775 (47.0) 
Used one 416 (25.2) 
Used two 303 (18.4) 
Used all three 155 (9.4) 






























B. Pre-colonoscopy Survey 
  
                                 Study ID: PT__/__ __ __ 
University of Florida 
Pre-Colonoscopy Survey -- Patient Version 
 
1. Would you say that in general your health is: (check one box only) 
   □1 Excellent      □2 Very Good      □3 Good       □4 Fair       □5 Poor       □6 Very poor 
 
2.  On a scale of 1 to 10, how anxious are you feeling TODAY? (circle one number) 
            Not at all anxious   1      2      3      4      5      6      7      8      9      10   Very Anxious 
 
3.  Did any of the following cause problems for you in getting the colonoscopy? 
    a.  Getting an appointment             □1 yes   □2 no 
    b.  Getting time off work                  □1 yes   □2 no  
    c.  Finding someone to come with you                               □1 yes   □2 no      
    d.  Getting a ride             □1 yes   □2 no 
    e.  My driver getting time off work       □1 yes   □2 no 
    f.   How much it costs         □1 yes   □2 no 
    g.  Arranging child or elder care       □1 yes   □2 no 
    h.  Other (What?_______________________________)                      □1 yes   □2 no 
 
4.  Before today, have you had any of the following communications about your colonoscopy? 
    a. Talked to the doctor doing the colonoscopy in person                         □1 yes    □2 no  
    b. Talked to the doctor doing the colonoscopy by phone                    □1 yes    □2 no 
    c. Talked to a nurse from the colonoscopy center in person                    □1 yes    □2 no 
    d. Talked to a nurse from the colonoscopy center by phone                    □1 yes    □2 no 
    e. Received materials by mail from the colonoscopy center                     □1 yes   □2 no 
    f.  Other (what?_______________________________________________) 
 
5.  How do you think you will get the results from your colonoscopy? 
      a.  Doctor doing the colonoscopy will tell me right afterwards                □1 yes   □2 no 
      b.  Doctor doing the colonoscopy will telephone me   □1 yes   □2 no 
      c.   Nurse from the colonoscopy center will tell me right afterwards                □1 yes   □2 no 
      d.  Nurse from the colonoscopy center will telephone me                □1 yes   □2 no 
      e.   I will get a printed report right afterwards    □1 yes   □2 no 
      f.     I will get a letter in the mail from the colonoscopy center               □1 yes   □2 no 
      g.  My personal doctor will tell me                   □1 yes   □2 no 
      h.   Other (how?____________________________________________________) 
 
6.  How would you MOST LIKE to get your results?  
       _________________________________________________________________   
 
 
7.  What do you expect the results of the colonoscopy will show?  
       _________________________________________________________________ 
 
8.  About how many minutes do you think the doctor will spend with you BEFORE your colonoscopy? 
 _______ minutes 
 







9.  About how many minutes do you think the doctor will spend with you AFTER your colonoscopy? 
 _______minutes 
 
10.  How much benefit (help) to your health is having a colonoscopy? (circle one number) 
       No benefit  at all     1      2      3      4      5      6      7      8      9      10    Very high benefit 
 
11.  How much risk (possible harm) to your health is having a colonoscopy? (circle one number) 
       No risk at all     1      2      3      4      5      6      7      8      9      10    Very high risk 
 
12.  In making your decision to have a colonoscopy, how much did you compare the benefits and risks? 
(circle one number) 
       Not at all     1      2      3      4      5      6      7      8      9      10    A great deal 
 
13.  Please circle the number for how much you agree or disagree with the following statements: 
1=strongly agree             2=agree                       3=neither/neutral  
 
















































a.  The decision to have a colonoscopy was hard to make. 1 2 3 4 5 
b.  I am satisfied with my decision to have a colonoscopy. 1 2 3 4 5 
c.  I felt pressure from other people to have a colonoscopy. 1 2 3 4 5 
d.  The decision to have a colonoscopy was largely my own. 1 2 3 4 5 
 
14.  How informed about colonoscopy do you think you are?  
   □1 Not at all      □2 Slightly      □3 Moderately       □4 Quite a lot     □5 Extremely 
 
15.  In your own words, what is a colonoscopy for? 
       ____________________________________________________________ 
 
16.  How confident are you that your bowel is totally clean for the colonoscopy?  (circle  one number) 
       Not at all confident     1      2      3      4      5      6      7      8      9      10    Very confident 
 
PART 2:  ABOUT YOU 
17. How confident are you filling out medical forms by yourself? 
       □1 Extremely      □2 Quite a bit     □3 Somewhat       □4 A little bit      □5 Not at all 
 
18. How often do you have someone help you read medical materials? 
       □1 Always      □2 Often     □3 Sometimes       □4 Occasionally      □5 Never 
 
19.  How often do you have problems learning about your medical condition because of difficulty 
understanding written information? 
       □1 Always      □2 Often     □3 Sometimes       □4 Occasionally      □5 Never 
 
20.  How often do you feel you don’t understand what doctors tell you? 
       □1 Always      □2 Often     □3 Sometimes       □4 Occasionally      □5 Never 
 
21. How informed about colon and rectal cancer do you think you are?  
       □1 Not at all      □2 Slightly      □3 Moderately       □4 Quite a lot     □5 Extremely 
 
22.  How concerned are you about having colon or rectal cancer?  
       □1 Not at all      □2 Slightly      □3 Moderately       □4 Quite a lot     □5 Extremely 
 







1=strongly agree          2=agree                        3=neither/neutral      
 















































a.  Doctors treat some patients better than others. 1 2 3 4 5 
b.  Doctors treat minorities worse than white people. 1 2 3 4 5 
c.  Doctors treat poor people worse than rich people. 1 2 3 4 5 
d.  Doctors treat me the same as other patients. 1 2 3 4 5 
e.  Doctors treat people who don’t speak English worse than  
     those who do speak English. 
1 2 3 4 5 
f.   Doctors treat people with low education worse than people  
     with a lot of education. 
1 2 3 4 5 
g.  Doctors treat women worse than men. 1 2 3 4 5 
h.  Doctors treat people on Medicaid worse than people with  
     private insurance. 
1 2 3 4 5 
i.   I can usually count on being treated with respect by doctors. 1 2 3 4 5 
j.   I trust that I will get the best care no matter what the costs. 1 2 3 4 5 
k. I trust what the doctors tell me. 1 2 3 4 5 
l.  I trust that hospitals will provide me with the best care  
    possible. 
1 2 3 4 5 
 
 
24.  Please circle the number for how much you agree or disagree with the following statements: 
 
1=strongly agree          2=agree                        
3=neither/neutral      
 














































 a.  If I had cancer I would do whatever it takes to beat it. 1 2 3 4 5 
b.  If I had cancer I would take a wait and see approach. 1 2 3 4 5 
c.  If I had cancer I would want my doctor to make the  
     treatment decisions. 
1 2 3 4 5 
d.  If I had cancer I would gather as much information as  
     possible before I decided on treatment . 
1 2 3 4 5 
e.  If I had cancer I would willingly have surgery to beat it. 1 2 3 4 5 
f.   If I had cancer I would willingly have chemotherapy   
     (cancer drugs) to beat it. 
1 2 3 4 5 
g.  If I had cancer I would willingly have radiation to beat it. 1 2 3 4 5 
h.  If I had cancer I would willingly try an experimental  
     treatment to beat it. 
1 2 3 4 5 
i.   If I had cancer I would worry about being a burden on  
     my family. 
1 2 3 4 5 
j.  When there is more than one method to treat a problem, I  
     should be told about each one. 
1 2 3 4 5 
k.  I believe that my doctor needs to know everything about  
    my medical history to take good care of me. 
1 2 3 4 5 
l.  I would rather have my doctor make decisions about  
     what’s best for my health than to be given a whole lot of  
     choices. 
1 2 3 4 5 







     doctor, not by me. 
 
PART 3: YOUR COLONOSCOPY  
25.  Is this your first colonoscopy? (check one box only) 
    □1 Yes, and it is the first time it was recommended 
    □2 Yes, but it was recommended to me before  
    □3 No (How many have you had before?_______________________) 
 
26.  Who ordered this colonoscopy for you? (check one box only) 
    □1 My regular doctor/family doctor 
    □2 Some other doctor (What type of doctor?___________________       ) 
    □3 Some other health care provider (What type of provider?__________) 
 
27.  To the best of your knowledge, why was this colonoscopy ordered?  
    a. Routine based on my age     □1 yes   □2 no 
    b. Family history of colon or rectal cancer                 □1 yes   □2 no 
    c. Follow-up to a previous colonoscopy                 □1 yes   □2 no 
    d. Follow-up to an abnormal test     □1 yes   □2 no 
    e. I have been having symptoms or problems                 □1 yes   □2 no 
    f.   I asked for the test (Why?_____________________)                     □1 yes   □2 no 
    g. A family member insisted (Why?_______________ )                    □1 yes   □2 no 
    h. Other reason (What?_____________________________________) 
 
28. How is your colonoscopy being paid for? (check one box only) 
    □1 Insurance, Medicare, Medicaid, or the VA will pay for all of it 
    □2 Insurance, Medicare, Medicaid, or the VA will pay for some of it  
    □3 I will pay for all of it 
    □4 Other (Who?____________________________________________) 
 
29.  Does having this colonoscopy put a financial strain on you or your family? 
    □1 Yes            □2 No  
     
30.  Do you think this colonoscopy will be worth the financial cost to you? 
    □1 yes            □2 no  
 
31.  Did you do any of the following on your own to learn more about colonoscopy? 
   a. Read about colonoscopy           □1 yes   □2 no 
   b. Looked up colonoscopy on the computer         □1 yes   □2 no  
   c. Talked with someone about their colonoscopy  (who?___)                     □1 yes   □2 no 
 
PART 4:  YOUR HEALTH  
 
32.  Please answer these questions about your health over the past 30 days: 
Over the past 30 days… Days 
a. Thinking about your physical health, which includes physical illness and injury, for how 
many days during the past 30 days was your physical health not good? 
 
b.  Thinking about your mental health, which includes stress, depression, and problems with 
emotions, for how many days during the past 30 days was your mental health not good? 
 
c. During the past 30 days, for about how many days did poor physical or mental health keep 
you from doing your usual activities, such as self-care, work, or recreation? 
 
d.  During the past 30 days, for about how many days did pain make it hard for you to do 



















33. This scale asks about your feelings and thoughts during the last month. Please circle how often you felt 
a certain way.  
 
0=Never           
1=Almost Never           
2=Sometimes      
3=Fairly Often                     



































a. In the last month, how often have you been upset because of 
something that happened unexpectedly? 
0 1 2 3 4 
b. In the last month, how often have you felt that you were 
unable to control the important things in your life? 
0 1 2 3 4 
c. In the last month, how often have you felt nervous and 
“stressed”? 
0 1 2 3 4 
d. In the last month, how often have you felt confident about 
your ability to handle your personal problems? 
0 1 2 3 4 
e. In the last month, how often have you felt that things were 
going your way? 
0 1 2 3 4 
f.   In the last month, how often have you found that you could 
not cope with all the things that you had to do?  
0 1 2 3 4 
g. In the last month, how often have you been able to control 
irritations in your life? 
0 1 2 3 4 
h. In the last month, how often have you felt that you were on 
top of things? 
0 1 2 3 4 
i.   In the last month, how often have you been angered because 
of things that were outside of your control?  
0 1 2 3 4 
j.   In the last month, how often have you felt difficulties were 
piling up so high that you could not overcome them? 
0 1 2 3 4 
 
34.  Do you have a regular doctor or other health care provider? 
    □1 yes             □2 no  
 
35.  Where do you get most of your health care? (check one box only)   
    □1 Doctor’s office/practice   □3 VA                        □5 Other (where?_____) 
    □2 Emergency room    □4 Urgent care clinic 
 
 
36.  Please tell us if you have taken the medications listed below every day or most  
     days during the past 6 months: 
 a.  Multi-vitamins          □1 yes   □2 no   
 b.  Aspirin                     □1 yes   □2 no   
 c.  Calcium          □1 yes   □2 no   
 d.  Vitamin C          □1 yes   □2 no            







 f.   Statins (for cholesterol)                   □1 yes   □2 no 
 g.  Coumadin (blood thinner)                □1 yes   □2 no 
 h.  Fish oil                    □1 yes   □2 no 
 
37.  Please tell us if you have ever used any of the types of tobacco listed below: 
Have you ever used? Never Used Use now Used before but quit 
a. Cigarettes □1 □2 
How much per day?_____ 
□3 
When quit? ____________ 
b. Cigars □1 □2 
How much per day?_____ 
□3 
When quit? ____________ 
c. Pipe □1 □2 
How much per day?_____ 
□3 
When quit? ____________ 
d. Smokeless (dip,  
    snuff, chew) 
□1 □2 
How much per day?_____ 
□3 
When quit? ____________ 
 
38.  What is your zip code?  _________  
 
39.  What is your relationship to the person who came with you today? (check one box only)     
 
    □1 Spouse/partner                  □4 Friend or neighbor 
    □2 Other family member:______                            □5 Pastor or a church member 
    □3 Co-worker                 □6 Someone else:____________ 
     
     
 
40.  Do you live at the same address as the person who brought you? 




Thank you for your help! 
Please answer the questions below – we will cut off this portion of the 







 What is the best phone number for you?  
_______________________________ 
 What is the best time to call you?             
_______________________________ 













































































October November December January February March April 
(week) 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 
Choose Research 
Question 
                              
Choose 
Committee 




                              
Chapter 1                               
Chapter 2                               
 Edited chapter 1                               
Chapter 3                               
 Edited chapter 2                               
Edited chapter 3                               
Full Paper                               
Send paper to 
committee 
                              
Book room for 
proposal defense 
                              
Proposal Defense                                
Actual Defense                               
Proposal 
revisions 
                              
Full paper with 
all revisions 
                              
Book room for 
proposal defense 
                              
Full paper to 
committee 
                              
Proposal Defense                               
Chapter 1- 3 
revisions 
                              
Chapter 4 and 5 
outline 





















 September October November December January February March April 







                              
Analysis-
Research 
Question 1  




                              
Data 
Interpretation 
                              
Chapter 4                               
      Revision 1                               
      Revision 2                               
Chapter 5                               
      Revision 1                               
      Revision 2                               
Full Paper                               
     Revision 1                               
     Revision 2                               
     Meet with 
Dr. Curbow 
                              
     Meet with 
Dr. Garza 
                              
     Committee 
revisions 





                              
Final draft to 
committee 
                              










Acott, A., Theus, S., Marchant-Miros, K., & Mancino, A., F.A.C.S. (2008). Association 
of tobacco and alcohol use with earlier development of colorectal cancer: Should 
we modify screening guidelines? The American Journal of Surgery, 196(6), 915-
919. doi:10.1016/j.amjsurg.2008.07.033 
 
Albert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., ... 
& Manson, J. E. (2008). Effect of folic acid and B vitamins on risk of 
cardiovascular events and total mortality among women at high risk for 
cardiovascular disease: a randomized trial. Jama, 299(17), 2027-2036. 
Algra, A.M., Rothwell, P.M. (2012). Effects of regular aspirin on long-term cancer 
incidence and metastasis: a systematic comparison of evidence from observational 
studies versus randomised trials. Lancet Oncology, 13(5):518. 
 
American Cancer Society. (2017). American Cancer Society Recommendations for 
Colorectal Cancer Early Detection. https://www.cancer.org/cancer/colon-rectal-
cancer/detection-diagnosis-staging/acs-recommendations.html 
 





American Cancer society. (2017). What is Colorectal Cancer? 
https://www.cancer.org/cancer/colon-rectal-cancer/about/what-is-colorectal-cancer.html 
 




American Cancer Society. (2015). What is Cancer. 
https://www.cancer.org/cancer/cancer-basics/what-is-cancer.html 
 
Ann Chao, Michael J. Thun, Eric J. Jacobs, S. Jane Henley, Carmen Rodriguez, Eugenia 
E. Calle; Cigarette Smoking and Colorectal Cancer Mortality in the Cancer 
Prevention Study II, JNCI: Journal of the National Cancer Institute, Volume 92, 





Bailey, R. L., Fulgoni III, V. L., Keast, D. R., & Dwyer, J. T. (2011). Dietary supplement 
use is associated with higher intakes of minerals from food sources–. The 








Bell, R. (2015). CANCER. Science, 6238, 1036-1039. 
 
Bibbins-Domingo K, U.S. Preventive Services Task Force. (2016). Aspirin use for the 
primary prevention of cardiovascular disease and colorectal cancer: U.S. 
preventive services task force recommendation statement. Annals of Internal 
Medicine,164(12), 836-45. doi:10.7326/M16-0577 
 
Blumberg, JB., Frei, B., Fulgoni VL 3rd, Weaver, CM., Zeisel, SH.  (2016). Vitamin and 
mineral intake is inadequate for most Americans: What should we advise patients 
about supplements? Journal of Family Practice;65(9), S1-S8. 
 
Blumberg, J., Frei, B., Fulgoni, V., Weaver, C., & Zeisel, S. (2017). Contribution of 
dietary supplements to nutritional adequacy in various adult age 
groups. Nutrients, 9(12), 1325-1325. doi:10.3390/nu9121325 
 
Blumberg, J., Frei, B., Fulgoni, V., Weaver, C., & Zeisel, S. (2017). Contribution of 
dietary supplements to nutritional adequacy in Race/Ethnic Populations 
Subgroups in the united states. Nutrients, 9(12). doi:10.3390/nu9121295 
 
Bond, J. H. (1999). Calcium supplements for the prevention of colorectal adenomas. New 
England Journal of Medicine, 340(2), 101-107. 
 
Brody, H. (2014). Cancer. Nature, 509(7502 Suppl), 49. doi:10.1038/509S49a 
 
Chung JY, Lee DH, Park JH, Lee MK, Kang DW, Min J, Kim DI, Jeong DH, Kim NK, 
Meyerhardt JA, Jones LW, Jeon JY. (2013). Patterns of physical activity 
participation across the cancer trajectory in colorectal cancer survivors. 
Supportive Care in Cancer: Official Journal of the Multinational Association of 
Supportive Care in Cancer, 21(6), 1605-12. doi:10.1007/s00520-012-1703-5 
 
Center for Disease Control and Prevention. (1993). 1993 Behavioral Risk Factor 
Questionnaire. Behavioral risk Factor surveillance System. 
 
Center for Disease Control and Prevention. (2015). Colorectal Cancer Risk by Age. 
https://www.cdc.gov/cancer/colorectal/statistics/age.htm 
Center for disease Control and Prevention. (2016). NHANES 2013-2014 Dietary Data: 
Dietary Supplement Use 30-Day - Total Dietary Supplements. 
https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/DSQTOT_H.htm 
 
Center for Disease Control and Prevention. (2017). Fact Sheets - Excessive Alcohol Use 
and Risks to Women's Health. https://www.cdc.gov/alcohol/fact-sheets/womens-
health.htm 
 









Chan, A. T., & Giovannucci, E. L. (2010). Primary prevention of colorectal cancer. 
Gastroenterology, 138(6), 2029-2043. 
 
Chitayat, D., Matsui, D., Amitai, Y., Kennedy, D., Vohra, S., Rieder, M., Koren, G. 
(2016). Folic acid supplementation for pregnant women and those planning 




Cho, E., Smith-Warner, S. A., Spiegelman, D., Beeson, W. L., van den Brandt, P. A., 
Colditz, G. A., ... & Goldbohm, R. A. (2004). Dairy foods, calcium, and 
colorectal cancer: a pooled analysis of 10 cohort studies. Journal of the National 
Cancer Institute, 96(13), 1015-1022 
 
Clarke  TC, Black  LI, Stussman  BJ, Barnes  PM, Nahin  RL. (2015). Trends in the use 
of complementary health approaches among adults: United States, 2002-
2012.  National Health Statistics Report;(79):1-16. 
 
Curbow, B.A., Dailey, A.B., King-Marshall, E.C., Barnett, T.E., Schumacher, J.R., 
Sultan, S., George, T.J. Jr. (2015). Pathways to colonoscopy in the south: Seeds of 
health disparities. American Journal of Public Health, 105(4), 103-11. 
doi:10.2105/AJPH.2014.302347 
 
Datta M, Vitolins MZ.  (2016). Food fortification and supplement use-Are there health 
implications? Critical Reviews in Food Science and Nutrition, 56(13), 2149-59. 
doi:10.1080/10408398.2013.818527 
 
Dickinson A, Blatman J, El-Dash N, Franco JC. (2014). Consumer usage and reasons for 
using dietary supplements: Report of a series of surveys. Journal of the American 
College of Nutrition, 33(2), 176-82. doi:10.1080/07315724.2013.875423 
 
Dickinson, A., MacKay, D., & Wong, A. (2015). Consumer attitudes about the role of 
multivitamins and other dietary supplements: report of a survey.Nutrition 
Journal, 14, 66. http://doi.org/10.1186/s12937-015-0053-9 
 
Fisher, P. (2016). Cancer and quality of life. Homeopathy, 105(4), 287-288. 
doi:10.1016/j.homp.2016.11.001 
 
Food and Drug Administration. (2017). Fortify our Knowledge about Vitamins. 
https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm118079.htm 
 










Foote, J.A., Murphy, S.P., Wilkens, L.R., Hankin, J.H., Henderson, B.E., Kolonel, L.N. 
(2003). Factors associated with dietary supplement use among healthy adults of 
five ethnicities: The multiethnic cohort study. American Journal of 
Epidemiology, 157(10), 888-97. 
 
Gahche, J.J., Potischman, N., Dwyer, J.T., Bailey, R.L. (2017). Dietary supplement use 
was very high among older adults in the United States in 2011-2014. Journal of 
Nutrition, 147(10), 1968-1976. doi:10.3945/jn.117.255984 
 
Glanz, K., Rimer, B., & National Cancer Institute (U.S.). (1997). Theory at a glance : A 
guide for health promotion practice (NIH publication, no. 97-3896). Bethesda? 
Md.: U.S. Dept. of Health and Human Services, Public Health Service, National 
Institutes of Health, National Cancer Institute. 
 
Golshiri, P., Rasooli, S., Emami, M., Najimi, A. (2016). Effects of physical activity on 
risk of colorectal cancer: A case-control study. International Journal of 
Preventive Medicine, 7, 32-32. doi:10.4103/2008-7802.175991 
 
Greiner, K., Born, W., Nollen, N., & Ahluwalia, J. (2005). Knowledge and perceptions of 
colorectal cancer screening among urban african americans. Journal of General 
Internal Medicine, 20(11), 977-983. doi:10.1111/j.1525-1497.2005.00165.x 
 
Harris,SS. (2006). Vitamin D and African Americans. The Journal of Nutrition, 136(4), 
1126-9. 
 
Heine-Broring, Renate C. Heine-Broring € 1 , Renate M. Winkels1 , Jacoba M.S. 
Renkema2 , Lea Kragt1 , Anne-Claire B. van Orten-Luiten1 , Ettje F. Tigchelaar1 
, Doris S.M. Chan3 , Teresa Norat3 and Kampman, E. (2015). Dietary supplement 
use and colorectal cancer risk: A systematic review and meta-analyses of 




Heydarnejad, M., Hassanpour, D. A., & Solati, D. K. (2011). Factors affecting quality of 
life in cancer patients undergoing chemotherapy. African Health Sciences, 11(2), 
266–270. 
 
Hoffmeister, M., Chang-Claude, J., & Brenner, H. (2007). Individual and joint use of 
statins and low-dose aspirin and risk of colorectal cancer: A population-based 
case-control study. International Journal of Cancer, 121(6), 1325-1330. 
doi:10.1002/ijc.22796 
 
Howard, R., Freedman, D., Park, Y., Hollenbeck, A., Schatzkin, A., & Leitzmann, M. 
(2008). Physical activity, sedentary behavior, and the risk of colon and rectal 







International Journal of Studies of Cancer in Human Populations, 19(9), 939-
953. doi:10.1007/s10552-008-9159-0 
 
Haun J, Dodd VJ, Varnass JW, Graham-Pole J, Rienzo B, Donaldson P. (2009). Testing 
the brief health literacy screening tool: Implications for utilization of a BRIEF 
health literacy indicator. Federal Pracitioner Journal, 26 (12):24-28, 30-31. 
 
Imai, T., Otsuka, R., Kato, Y., Ando, F., & Shimokata, H. (2015). A longitudinal study of 
dietary supplement use in community-living middle age and elderly japanese. 
International Journal of Epidemiology, 44(Suppl_1), 186. 
doi:10.1093/ije/dyv096.282 
 
Institute of Medicine. 2004. Health Literacy: A Prescription to End Confusion. 
Washington, DC: The National Academies Press. https://doi.org/10.17226/10883. 
 
Jaime J Gahche, Regan L Bailey, Nancy Potischman, Johanna T Dwyer; Dietary 
Supplement Use Was Very High among Older Adults in the United States in 
2011–2014, The Journal of Nutrition, Volume 147, Issue 10, 1 October 2017, 
Pages 1968–1976, https://doi.org/10.3945/jn.117.255984 
 
Jasti, S., Siega-Riz, AM., & Bentley, ME. (2003). Dietary supplement use in the context 
of health disparities: Cultural, ethnic and demographic determinants of use. The 
Journal of Nutrition, 133(6), 2010. 
 
Ji BT, Weissfeld JL, Chow WH, Huang WY, Schoen RE, Hayes RB. (2006). Tobacco 
smoking and colorectal hyperplastic and adenomatous polyps. Cancer 
Epidemiology, Biomarkers & Prevention : A Publication of the American 
Association for Cancer Research, Cosponsored by the American Society of 
Preventive Oncology, 15(5), 897-901. 
http://cebp.aacrjournals.org/content/15/5/897.full 
 
Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. (2016). Trends in Dietary 
Supplement Use Among US Adults From 1999-2012. Journal of American 
Medical Association; 316(14),1464–1474. doi:10.1001/jama.2016.14403 
 





King-Marshall, E., Mueller, N., Dailey, A., Barnett, T., George, T., Sultan, S., & Curbow, 
B. (2016). “It is just another test they want to do”: Patient and caregiver 
understanding of the colonoscopy procedure. Patient Education and Counseling, 








Lambert, M. (2014). ACC/AHA release updated guideline on the treatment of blood 
cholesterol to reduce aSCVD risk. American Family Physician, 90(4), 260. 
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